100,956,GST,HOWEVER,MNO,PCR,PEG,ROS
140,169,AUTHORS,EXPRESSION,FGF23,LIMITED,PRESS,THESE
001,097,153,773,BIM,DCR,ELECTRONIC,HOWEVER,NSCLC,ORR,PFS,TKI
169,FMS,MAM,USING
109,120,169,197,235,238,289,339,938,BASED,COPYRIGHT,ENTROPY,INC,KIT,NGS,SEQUENCING,SHANNON,THERE
169,GENOMIC,LABORATORY,PRESS,PUBLISHED
AKT,BMP,HOWEVER,NSCLC,SMAD1,SQCCS,TARGETING,TKI
224,945,DESPITE,ERK,HOWEVER,INCREASED,LOCAL,NSCLC,SMAD4,TNF,TNFAIP1
169,500,COPYRIGHT,EXPRESSION,KNOCKDOWN,PRR11,REMARKABLY,SIRNA
169,358,716,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,IIFESTYLE,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TAIWANESE,XRCC3
169,231,233,ALK,COPYRIGHT,HOWEVER,HSP,INHIBITORS,INTERGROUP,NON,NSCLC,PFS,PROTEIN,PUBLI,PUBLISHED,SAS,SHOCK,SMALL,STRATEGIES,THESE
169,946,954,BIOLOGY,FINALLY,FURTHER,INC,K11,K48,LPS,MOLECULAR,NFKB2,PAGET,PARTIAL,SCF,SOCIETY
035,169,312,353,355,ACCORDING,ALLELIC,AMONG,ASIAN,BPH,COPYRIGHT,DUE,GENOTYPING,HRM,INC,MINOR,PCA,PCR,PSA,SERBIAN
160,169,ASP,BAX,CADM1,COPYRIGHT,FOXA2,GLU,HDAC1,HDAC3,HOWEVER,HSP,INC,NR0B2,THESE
169,CCC,CCG,CGC,CHRONIC,COPYRIGHT,HOWEVER,III,INC,MECHANISMS,SELECTION,SER15,TCG,THESE
001,169,239,BACKGROUND,DEPLETION,E2F,HOWEVER,LABEL,MEIER,METHODS,MICROARRAY,PHD,PRESS,PUBLISHED,RESULTS,STUDENT,THESE,UHRF1,UNIVERSITY
169,764,AKT,APC,BON,BRCA1,COPYRIGHT,EP300,EXCAVATOR,INC,KDR,NCI,NET,RB1,STK11,THESE,UMC11,YY1
100,30C,954,FINALLY,HOWEVER,TNF,TRAIL
169,COPYRIGHT,FRA,LPS,PCR,PREVIOUSLY,SOCIETY,WESTERN
169,946,COPYRIGHT,EMT,IRELAND,LRRFIP1,LTD,SILENCING,WNT
100,ABI,APPLIED,BIOSYSTEMS,BLAST,CONCLUSION,DAB,DENMARK,FFPBS,KIT,LABEL,METHODS,OBJECTIVE,PCR,POLYMERASE,PRISM,QIAMP,RESULTS,STATISTICA,USA
169,BIOLOGY,CONSISTENT,FOS,INC,INDUCIBLE,JUN,MOLECULAR,PREVIOUSLY,SOCIETY,TAP73,THESE
169,ACS,AMONG,CNA,COPYRIGHT,HOWEVER,III,INC,NSCLC,SCC
169,304,946,947,948,949,950,951,952,963,964,ABD,COPYRIGHT,HOWEVER,INHIBITION,MOL,NCI,PHYSIOL,SOCIETY,UTR
169,916,ALTOGETHER,BIOLOGY,FINALLY,HIPPO,INC,MOLECULAR,PDZ,SOCIETY,TAZ
169,ALK,ANTICANCER,ATM,COPYRIGHT,INSTITUTE,KIRSTEN,NSCLC,STK11,TESTING
ALK,NSCLC
215,365,809,ABCA1,ACOT4,AFRICAN,AMERICANS,BLOOD,DISCOVERY,ESP,EXOME,HEART,IMPORTANCE,INSTITUTE,JANUARY,LABEL,METHODS,NHLBI,OBJECTIVE,PDE4DIP,PROJECT,RELEVANCE,RESULTS,SEQUENCING,SETTING,THESE,ZFHX3
001,006,1544C,169,20Q11,215,348,699,915,998,COPYRIGHT,FKBPL,HOWEVER,INC,PRO137LEU,PRO515LEU,PUBLISHED,SOCIETY,VAL284MET
093,169,496,638,735,CLPTM1L,HOWEVER,ISRAELI,SMOKING
169,227,AFRICAN,AMERICANS,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMARCA4,SOCIETY
160,INC,PUBLISHED,TYPICAL
169,956,COPYRIGHT,INC,PCR
AMONG,FURTHER,LABEL,METHODS,OBJECTIVE,POLYMERASE,RESULTS,TA5,TA7,UGT,UTG
160,169,214,945,ABNORMALLY,AUTHORS,EPO,FDA,FINALLY,HIF,JOURNAL,PHT,PLACENTAL,SCD,SOCIETY,THESE,UTR
946,FOXQ1,INCREASED,LAMA4,THESE,THROUGH
169,ADDITIONAL,ASTN1,CSMD2,EXOME,EXPRESSION,MUTATED,PRESS,PUBLISHED,RB1,SCLCS,SMALL,SPTA1,THEREFORE,UNIVERSITY
169,200,230,ALK,LADCS,RET,SNF,SWI,THESE,WHOLE
169,COPYRIGHT,INC,KEAP1,WHOLE
169,ALK,AMONG,COPYRIGHT,FGFR1,LTD,MET,NSCLC,RET
HOWEVER,PCR,SGMS1
954,EPIGENETIC,MEDIP,THESE,USING
100,APC,CRC,FBXW7,SMAD4,SOMATIC,SYNE1
041,075,172,239,239PU,439,849,945,947,CONTROL,EXB,GSTM1,GSTP1,GSTT1,HARDY,ILE105VAL,MAYAK,MAYAL,NAT,THREE
500,946,EIGHT,H1299,ITGB3BP,SHC,SRPK1,USING
160,169,COPYRIGHT,H3K4ME1,HISTONE,HOWEVER,INC,OGT
100,693,ADC,ALU,CPG,STAGE
109,149,169,452,946,956,AHR,COPYRIGHT,CZECH,EOM,PM2,TGF,WNT
169,392,946,BIOLOGY,ERK,INC,MH2,MOLECULAR,R175H,SER,SILENCING,SMAD2,SMAD3,SMAD4,SOCIETY,TGF
NSCLC
FURTHER,NSCLC,OCTOBER,ORS
EARLY,FAM107A,MSP,NSCLC,TOTAL,TSG
169,215,COPYRIGHT,EIGHT,OVERALL,THEREFORE
169,405,624,COPYRIGHT,INC,INDIVIDUAL
169,COPYRIGHT,DELETED,DIFFERENT,DLEC1,HNSCC,HOWEVER,PCR
169,233,HOWEVER,PCR,THESE
100,854,ACTIONABLE,AGENA,AUSTRALIA,BACKGROUND,BIOSCIENCE,LABEL,MASSARRAY,METHODS,MPS,OVERALL,PANEL,RESULTS,WHEREAS
328,543,ARG458X,BACKGROUND,BAX,FUNCTIONAL,LABEL,LYS469GLU,METHODS,NEITHER,NSCLC,PPM1D,RESULTS,THEIR,THESE
15Q12,169,215,BACKGROUND,DETECTION,GABAERGIC,LABEL,METHODS,PATHWAY,PRESS,PUBLISHED,RESULTS,RS73371737,UNIVERSITY
CPG,IGE,THERAPIES
169,AUTHORS,HOWEVER,LTD,PTY,PUBLISHING,SCIENCE,WILEY
169,EPIGENOMIC,INCREASED,KCA,KCNN4,NSCLC
100,417,483,ABCG5,ABCG8,CALIFORNIA,CNV,DAVID,EXPRESSION,FINALLY,KO05223,LABEL,MATERIALS,MEANWHILE,METHODS,NUCLEOTIDE,OBJECTIVE,OMNIBUS,PENNCNV,RESULTS,SANTA,SNP,UNIVERSITY
245,AKT,EGF,ERK,ETS,H1299,INHIBITORS,MAD,MYC,SNP,THESE,USING
004,100,31G,9904341,PCR,PRESENTLY
AFTER,BACKGROUND,EPIGENETIC,EXPRESSION,H1299,LABEL,LUCIFERASE,METHODS,MMP,MSP,PCR,RESULTS,WESTERN
ALK,EPIDERMAL,NON,NSCLC,THEIR,TKI
160,215,224,339,BMI,METABOCHIP,OBESITY,PATHWAY
160,215,224,459,BMI,PATHWAY
100,2279744,309,309GG,309TT,EXPRESSION,NON,PRESENTLY,T309G
169,AKT,ASIAN,CAUCASIAN,FGFR1,PRESS,PUBLISHED,RET,TARGETING,THESE,UNIVERSITY,WHILE

169,AKT,ALK,COMPLETION,CONCLUSION,ERBB2,KIT,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX,SOCIETY
169,CONVERSELY,COPYRIGHT,H1299,HN6,SOCIETY,TAKEN,THESE,WHEREAS
029,169,566,669,749,ABCB1,ATP,B17,CYP2A13,FASEB,FOXA2,III,INHALED,MDR,R257C,TAP,THEIR,UDP,UGT2B17
CURRENT,DESPITE,IDIOPATHIC,IPF
036,042,043,228,301,501,CHINESE,HAN,HOWEVER,RS8042059,SEVENTEEN
001,036,037,121,HOWEVER,NSCLC,PCR,THEREFORE,WNT,WNT7A
COEXISTENT,OPHN1,OTHER,PECOMAS,PSF,RRAGB,ST3GAL1,TSC
ALK,GENOMIC,UNIFIED
169,198,351,522,708,906,COPYRIGHT,CPG,DESPITE,EPIGENETIC,INC,THERE,THESE,USING
001,011,012,021,169,BACKGROUND,BSP,COPYRIGHT,CPG,EPIGENETIC,INC,LABEL,METHODS,MSP,NPTX1,PCR,RESULTS,THESE,TNM
169,COLORECTAL,COPYRIGHT,CPG,CUR,CURCUMA,DELETED,DLEC1,HDAC4,INC,KNOCKDOWN,MSP,TAKEN
169,AKT,CDR,CONCLUSION,COPYRIGHT,CPG,EGR,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PC9,PCR,RESULTS,TREATMENT
CONVERSELY,NON,THESE
169,BACKGROUND,BASEL,CONCLUSION,H1299,H1568,LABEL,METHODS,MTT,MYC,NSCLC,PCR,RESULTS,TUNEL,WT1
003,BSP,HOWEVER,NSCLC,PCR,TMA
34C,DAC,ECTOPIC,HOWEVER,KNOCKDOWN,MET,NPC,PCR
169,ACIDS,AKT,CLINICALLY,HDAC1,HOWEVER,NOTABLY,NUCLEIC,OC4,PRESS,PUBLISHED,SP1,THROUGH,TNC,UNIVERSITY
169,231,233,254,APRIL,BACKGROUND,CEA,COPYRIGHT,FASAY,JANUARY,LABEL,LOUIS,METHODS,PFS,PUBLISHED,RESULTS,ROUTINE,SAINT,SAS,THERE
088,093,102,109,131,136,139,148,150,155,178,179,199,203,205,220,223,237,241,243,253,255,260,310,410,435,446,498,528,567,656,697,741,831,893,919,967,999,CIGARETTE,CONCLUSION,ERAP2,HAN,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SNP
038,105,166,167,946,III,NSCLC,RAR,SIMILAR,SINCE,THESE
001,002,034,177,272,544,BACKGROUND,INDIA,LABEL,MANIPUR,METHODS,MIZORAM,NORTH,PRO,RESULTS
ALK,FGFR1,NGS,NSCLC,SEVERAL
144,169,179,956,ANTICANCER,CONSOLE,COPYRIGHT,DMC,EXPRESSION,HOWEVER,INSTITUTE,MULTICHIP,NCI,RMA
008,010,1377G,196,379,844,844CC,AGE,APOPTOSIS,CHINA,FAS,HOWEVER,OCTOBER,PCR,SNP,SOUTH
169,891,946,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LABEL,LTD,LUCIFERASE,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SMAD3,SMAD4,SMADS,SPC,TGF,WESTERN
002,169,185,607,610,AMONG,COPYRIGHT,EIGHT,INC,REGULOMEDB,XRCC1
HOWEVER,TAKEN,THERE
001,006,037,141,169,174,259,279,456,950,ABCC4,ATP,BACKGROUND,COPYRIGHT,GST,LABEL,METHODS,OTHER,RESULTS,THESE
016,026,039,500,CHINESE,COX,HAN,MCT,MEIER,NON,NSCLC,RFS,SNP
025,227,CHINESE,DELC1,DLEC1,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
10Q25,349,457,609,731,AMONG,CLASS,CONSORTIUM,FLCCA,HAP,HLA,HOUSEHOLD,SOUTHEAST
1564A,3073A,320,346,ARG194TRP,ARG399GLN,CHINESE,XRCC1
169,BORCK,III,LABORATORY,POL,PRESS,PUBLISHED,TAKEN,TBP,WHOLE
1298A,ABCB1,AIM,CONCLUSION,ERCC1,LABEL,MATERIALS,METHODS,MTHFR,MTT,OBJECTIVE,PCR,RESULTS,THERE,THESE
BACKGROUND,ENDOMETRAL,HIF,HYPOXIA,LABEL,MATERIALS,METHODS,PCR,RESULTS
001,314,529,ACCORDING,HOWEVER,MEDLINE,NSCLC,OVERALL,PROQEST,RASSF1A,SCIENCE,STATA,WEB
156,238,ABL,AKT,CDK,CHINESE,ERBB2,FGFR1,FGFR3,KIT,MET,MOLECULAR,OTHERWISE,PCR,POLYGENIC,RET,SEVERAL,SIX,T790M,THERE,USING
130,169,COPYRIGHT,CPG,GISTS,KIT,SCIENCE,SDH,SIX,SUCCINATE
169,16Q23,BIOLOGY,DESPITE,SOCIETY
153,753,ATLAS,HIPPO,MET,NF1,THESE
120,ARG753GLN,ASP299GLY,ELISA,IGE,IRANIAN,PCR
033,041,228,301,CHINA,CHINESE,CIS,CLPTM1L,FURTHER,GTTATCTGT,HAN,HAPLOTYPE,ORS
129,255,ADS,ADTAV,E1A,ONCOLYTIC,TAV
946,AGE,BACKGROUND,CONCLUSION,DACT1,DACT2,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TGF,THERE,THESE,WNT
ABOUT,AMONG,AUTOMATIC,BACKGROUND,INTEGRATED,LABEL,NON,NSCLC,RESULTS,THESE,TINAGL1
100,126,182,205,356,601,ALTERED,BACKGROUND,CONCLUSION,LABEL,MENDELIAN,METHODS,RESULTS,RPS6KA3,SCC,THESE
10Q,215,640,AMONG,AWT,BACKGROUND,LABEL,MAGI2,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SNP,THREE
001,CPG,EXPRESSION,KNOWLEDGE,SCC
AKT,ERK,FGFR1,FGFR2,ITK,MEK,MOS,MST1R,NSCLC,NTRK1,NTRK2,ORF,PC9,SRC
CTC,EPCAM,HOWEVER,KEY,PATIENT
1082G,169,358,716,ANTICANCER,COPYRIGHT,FURTHER,INSTITUTE
10442,10869,14289,945,ASIAN,BACKGROUND,CIS,HIF,HOWEVER,LABEL,METHODS,ORS,RESULTS,SCIENCE,SIMILARLY,THEREFORE,WEB
169,COPYRIGHT,INC,MYC,SMALL,USING
160,190,217,793,AMONG,APOA5,III,LDL,MYOCARDIAL,PREVIOUSLY
578,AXL,BACKGROUND,ESRP1,GREATER,HOXB4,LABEL,RESULTS
946,CCND1,EGF,FINALLY,IFN,LAC,PML
CDK,HDAC1,HOWEVER,MICROARRAY,NSCLC,SP1,STRAP,THESE,USING
444,461,ADVERSE,NSCLC,PCR,THIRD
AKT,IGFBP,NSCLC
AKT,BRAIN,HOWEVER,OTHER,RAF,RASSF,RASSF1A,V600E
008,049,169,CXCR2,HOWEVER,IL8,SNP,USING,UTR
169,CONCLUSION,COPYRIGHT,DISCS,HOWEVER,INC,KNOCKDOWN,LABEL,MEIER,THESE,UNLABELLED
169,946,ANXA2,CONVERSELY,KMT1E,RESTORING,SMAD2,TGF
BACKGROUND,CURRENT,DESIRABLE,LABEL,OVERALL,RESULTS
001,002,2578C,460TT,BACKGROUND,BASED,CAUCASIANS,HOWEVER,LABEL,METHODS,RESULTS,SIMILAR,THESE
160,169,ALK,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ERBB2,IHC,INC,LABEL,MATERIALS,METHODS,PCR,PUBLISHED,RESULTS,RET
169,24H,AKR,AKR1B10,COPYRIGHT,ERK,HOWEVER,IRELAND,JUN,LTD,MAP,THESE,TPA,U0126
039,169,467,ASIAN,BACKGROUND,C216T,C228A,C228T,C229G,C250T,C295T,COPYRIGHT,G233C,G267C,IHC,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,RFS,TNM
BECAUSE,HOWEVER,OTHER,PRESENTLY,PRIMA,THESE
1A1,CONCLUSION,FNX01,IRINOTECAN,LABEL,MATERIALS,METHODS,OBJECTIVE,ORR,PFS,RESULTS,THERE
169,COPYRIGHT,IRELAND,KNOCKDOWN,LTD,PCR,THESE
169,COPYRIGHT,HOWEVER,INC,THESE
169,CISPLATIN,COPYRIGHT,FEDERATION,MAJOR,MVP,NON,NSCLC,PROTEIN,PUBLISHED,SMALL,SOCIETIES,THEREFORE,VAULT,WILMS,WT1
169,327,AHR,COPYRIGHT,GGGGC,INC,STATE,THESE
169,450,945,947,954,ACADEMY,ALLERGY,BACKGROUND,CD3,CD4,CONCLUSION,COPYRIGHT,GATA3,IFN,IGE,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,OVA,PUBLISHED,REMARKABLY,RESULTS,TH1,TH2,THESE,TNF
169,COPYRIGHT,CURRENT,DEVELOPING,FINALLY,LTD,PUBLISHED,THERAPIES,THESE
169,BCL,COPYRIGHT,DESPITE,HOWEVER,INC,NON,PACLITAXEL,PREVIOUSLY
100,115,120,121,CACTTTG,ECTOPIC,OVERALL,SOX,SOX30,SRY
001,AGE,ALK,NSCLC,ROC,THESE
169,COPYRIGHT,FINALLY,IRELAND,LFS,LTD,TKI
169,309GG,331,501,532,717,749,830,AUTHORS,CONSISTENT,INC,PUBLISHED,SNP285C,SNP285G,SNP309T,WILEY
001,118,EMT,EPITHELIAL,EXPRESSION,HOWEVER,THERE,TWIST
ALCOHOL,ALDH2,CURRENTLY,GROUP,HOWEVER
169,COPYRIGHT,DAI,LOW,SNP,THESE
062,199,364,611,673,835,BACKGROUND,CHINESE,CLPTM1L,HOWEVER,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,RS31489,SENSITIVE
001,003,031,042,053,056,178,241,359,365,382,419,587,768,841,916,930,974,BESIDES,HAN,INNER,LABEL,MATERIALS,METHODS,MONGOLIAN,OBJECTIVE,PCR,PURPOSE,RESULTS,SMOKERS
EPIGENETIC,GROUP,HAART,HIV,HODGKIN,HOWEVER,INSTITUTES,NHL,NIH,NOW,SCIENTIFIC,SOCIETY,WORKING
107,160,169,AUTHORS,EPIGENETIC,HPV,LTD,PCDHA13,TESTING,WILEY
945,946,BROAD,THERE
356,ALK,BACKGROUND,CHINESE,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,STUDIES,TKI
350,397,500,CHINESE,CONCLUSION,MAF,METHODS,NSCLC,PHACTR2,RESULTS
143,946,AZA,CATENIN,NSCLC,PCR,SPC,SUBSEQUENT,TNM,WNT,WNT3A
00027,215,650,BACKGROUND,CCP,COX,LABEL,METHODS,RESULTS,USING
141,222,CSF,FIFTY,FOXL1,POU,SP1,THESE
470,AFTER,ASSAY,CFI,CHINESE,COMPLEMENT,GENOTYPING,HAPLOVIEW,MASSARRAY,NSCLC,ORS,THERE,TOTALLY
640,915,ASIAN,CIS,CRUDE,GROWING,ORS,SEPTEMBER,STATA
EMT,ENA,HOWEVER,REVERSE
169,199A2,945,BINDING,BIOLOGY,ENDOTHELIN,HIF,HOWEVER,INC,MOLECULAR,SCD,SOCIETY,UTR
200,247,CONCLUSION,GSTM1,GSTP1,GSTT1,ILE462VAL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,PORTUGUESE,RESULTS,TOBACCO
CURRENTLY,NON,NSCLC,USING
INTRAVITAL,KIF22,KIF2C,NOTCH,SRF,SUBSEQUENT
169,217,385,536,552,573,ACIDS,H3K27AC,H3K4ME1,H3K4ME3,NUCLEIC,PRESS,PUBLISHED,SEQ,UNIVERSITY
169,322,ACIDS,DBTSS,NUCLEIC,PRESS,PUBLISHED,RELEASE,SINCE,SNV,TSS,UNIVERSITY
113,116,17A,17F,469,7488A,BACKGROUND,LABEL,MATERIALS,METHODS,PCR,RESULTS
945,946,947,948,AMONG,BASED,DUSP1,ERK,HOWEVER,JNK,JUN,MAP,MEK,MITOGEN,RAF,RAS,SEVERAL,THERE
129,155,BACKGROUND,EMT,FURTHER,HOWEVER,LABEL,MCRS1,METHODS,MICROARRAY,MIR,NSCLC,PCR,RESULTS,RETROVIRUS,SYSTEMATIC,UTR
169,946,HOWEVER,INC,TGF,THEREFORE,WILEY
001,282,803,ARID2,BAF,CATALOGUE,MUTATIONS,PEARSON,SMARCA4,SNF,SOMATIC,SWI,THEREFORE
002,ABCB4,ATP,CPG,EPIGENETIC,SILENCING
EBV,EPSTEIN,HLA,NPC
192,CPG,LA2,MNU,THESE
CURRENT,RAS,REDUNDANT
231,946,CULTURE,HOWEVER,MDA,PCR,PTHRP,RWGT2,STROMAL,TCF,TGF,THEREFORE,THESE,WHILE,WNT,WNT3A
015,020,022,028,169,CDR,DTC,HERC5,NSCLC,PCR,QRT,SEVEN,STAGE
CD40L,HOWEVER,THESE
129,160,ALK,ASIAN,BACKGROUND,BASED,DESPITE,FGFR1,FGFR2,KIF5B,LABEL,MET,METHODS,PCR,RESULTS,RET,THESE
ABCB1,ABCC1,ABCG2,AFTER,AIM,CONCLUSION,ERCC4,GENOMIC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,XPC
001,010,066,087,179,186,287,297,481,580,838,861,ASIAN,CHINESE,CIS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORS,RASSF1A,RESULTS
169,AGAINST,FINALLY,JOURNAL
149,196A2,499,ASIAN,BACKGROUND,CAUCASIAN,CONFIDENCE,DISEASE,INTERVALS,LABEL,METHODS,NON,OVERALL,RECURRENCE,RESULTS,SMALL
CRE,HOWEVER,USING
CID,COMBINING,E1A,HOWEVER,KNOCKDOWN,MSC,NSCLC,THESE,TREATMENT
169,946,AD5,BACKGROUND,BASEL,GFP,INF,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PILOT,RESULTS,SIMILAR,STENT,THESE
64257,64258,AVULAVIRUS,EARLY,FMK,HOWEVER,MTT,NDV,NEWCASTLE,PCR,RVG,THEREFORE,VAD
169,252,COPYRIGHT,FEDERATION,FOXO1,NSCLC,P21,P27,POK,POZ,PUBLISHED,SOCIETIES,THEREFORE
169,ALK,AMP,CAP,COLLEGE,CONCLUSION,DISCUSSION,IASLC,LABEL,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PURPOSE,RESULTS,SOCIETY
ADP,CBP,H2B,K12,THROUGH,USING
169,CANCERS,COPYRIGHT,ITH,SCIENCE,THESE,WES
946,ECTOPIC,EMT,EPITHELIAL,FOS,FRA,INHIBITING,MOLECULAR,TGF
169,ATM,ATMIN,BIOLOGISTS,COMPANY,DEPLETION,DYNC2H1,EXPRESSION,H210Q,IFT,INITIALLY,LC8,LTD,PUBLISHED,WDR34
CBP,CHROMATIN,CONVERSELY,HOWEVER,INHIBITION,SP1
AMONG,CHRONIC,LABEL,MATERIALS,METHODS,MMP12,OBJECTIVE,RESULTS,THERE,TIMP1
AMONG,BACKGROUND,LABEL,METHODS,MST,NSCLC,PCR,RESULTS,THESE
946,CHROMATIN,EMT,EPITHELIAL,EPRAS,FOXQ1,NOTABLY,PCR,TGF,WOUND
000,253,288,423,500,697,700,946,USING,WNT
001,169,AFRICAN,CHRNA,CHRNB,FURTHER,GIVEN,SNP,UTR
122,124,169,695,BEADARRAYS,HOWEVER,KEAP1,LABEL,LCNEC,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMARCA4,SQCCS,STK11,SUBGROUPS,WHOLE
169,COPYRIGHT,LTD,PEGYLATION,PEI,TAKEN
17P,233,AKT,DUB,ERK,RENAL
169,ANTICANCER,CLASSICAL,COPYRIGHT,INSTITUTE
000,BASED,GWASS,LOG,MINUS,OTHER,SELECTING,SNP,SUCCESSFUL
037,045,047,051,FURTHER,MENDELIAN,OVERALL,THERE,TOTAL,USING,WMD
023,041,CHINESE,LOW,PXR,THESE,UTR
185,945,946,CD8,CONCLUSION,HLA,LABEL,METHODS,OBJECTIVE,RESULTS,TCR,THESE,WT1
200,272,318,CD133,CRTC2,NSCLC,NSCLS,PCR,PREVIOUSLY,PROM1
28A,946,AD5,ADF35,BACKGROUND,CAR,EXPRESSION,LABEL,METHODS,RESULTS
ACA,ALK,BACKGROUND,CONTEXT,ERBB2,LABEL,METHODS,OBJECTIVE,RET,SOURCES
017,029,031,045,967,CHINESE,HAN
169,332,ALK,ANAPLASTIC,BAR,CLB,ERK,HOWEVER,INC,SAMPLES,STAT3,TAKEN,THESE,WHEREAS,WILEY
100,169,382,530,ACIDS,MSG,NUCLEIC,PRESS,PUBLISHED,REDUCED,UNIVERSITY
169,409,CONCLUSION,COPYRIGHT,IGF1R,INGENUITY,ION,IRELAND,KIT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PANEL,PGM,PROVEAN,RESULTS,SEQUENCER,THERE,VARIANT
167,ANXIETY,FCS,HOWEVER,IL1,IL1R2,LABEL,METHODS,NFKB2,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,USING,VARIATIONS
028,169,BACKGROUND,CONCLUSION,COPYRIGHT,ERCC1,EXPRESSION,FIFTY,GENOMIC,GREATER,HOWEVER,INC,INSERTION,LABEL,METHODS,MTHFR,PEMETREXED,PFS,RESULTS,SNP,USING,UTR
169,ACIDS,MIZ,NUCLEIC,POK,PRESS,PUBLISHED,SHORT,UNIVERSITY,ZNF509L
945,AFTER,BILATERAL,HEPATIC
110,130,160,169,CHINESE,COPYRIGHT,HOWEVER,IL6ST,INC,PCR,PROTEIN,STAT3
001,215,AS1,ASSET,BRC,IFNW1,PRC,PRESS,PUBLISHED,RCC,RS10511729,SNP,TUSC1,UNIVERSITY
DETECTION,TELOMERASE,TELOMERES
003,007,215,347,661,CLPTM1L,GWA,HOWEVER,RESULTS,SEVERAL
REGUCALCIN
ALK,DESPITE,LABEL,NSCLC,OPINION,STATEMENT,UNASSIGNED
100,177,200,400,ADENOVIRUS,BAL,BAX,CLEAVED,CONCLUSION,CONTROL,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,SER,SIRT6,WESTERN
480,BACKGROUND,BRIEFLY,COBAS,DEL,G718X,L858R,LABEL,MATERIALS,METHODS,PAKISTANI,PCR,RESULTS,S768I
500,ACACA,COX,DNL,EIGHT,FURTHER,HOWEVER,MEIER,NSCLC,SNP,UNDER
ADDRESSING,BACKGROUND,LABEL,METHODS,OVERALL,PCG,RESULTS
013,015,018,027,042,045,188,217,240,489,528,543,566,595,625,637,643,645,AFTER,CHINESE,LABEL,METHODS,OBJECTIVE,RESULTS
000,001,002,007,039,169,174,295,832,ABI,AFFYMETRIX,AGILENT,ARRAY,AUTHORS,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,INTEGRATED,IRELAND,LABEL,LOWER,LTD,MAPPING,MATERIALS,METHODS,NORTH,NSCLC,PUBLISHED,RESULTS,ROC,SNP,STY,UNIVERSITY
21E,536,ATLANTA,COX,CPG,FDR,GOLDENGATE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SILENCING
005,025,101,149,169,ACCORDING,COX,GASC1,MYC,NANOG,PPARG,ROC,THEREFORE
675,AMONG,BACKGROUND,EXPRESSION,GEO,INGENUITY,LABEL,MATERIALS,METHODS,MICRORNAS,OMNIBUS,RB1,RESULTS,TEN
169,AUTHORS,BCL6B,CLL,COPYRIGHT,ECTOPIC,HCC,HEPG2,HIV,IRELAND,LTD,MHCC97L,PUBLISHED,TAT,VEGFA
001,112,198,273,AMONG,CFE,COOKING,EPIDERMAL,KNOWLEDGE,NSCLC,OBJECTIVE,ORR,PFS,TKI
BRAZILIAN,MALIGNANT
CURRENT,HOWEVER,III,MTT,NAD,NSCLC,SIRT6,TAKEN
169,946,DAPK1,EARLY,EBV,EPSTEIN,HOWEVER,HRM,NPC,RAR,RASSF1A,SINCE,VIRUS
CCA,CSA,MUTATIONS,TRNT1,USING
169,215,414,945,949,AAS,AFRICAN,AMERICANS,CRP,DESPITE,EAS,ESP,HNF1A,NHLBI,PRESS,PUBLISHED,UNIVERSITY
15Q25,169,215,339,363,420,CANADIANS,PRESS,PUBLISHED,UNIVERSITY
346,EGF,ERLOTINIB,GEFITINIB,HOWEVER,NOMINALLY,THESE,UNREPORTED
169,BACKGROUND,BMJ,DIFFERENT,FEV,FVC,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEVERAL,SIGNALLING,SNP
182,METASTASIS,MICRORNAS,NOTABLY,THESE
204,CHRONIC,SNP,STUDIES
CK7,CLCA2,CTC,CURRENTLY,DETECTION,HOWEVER,PCR,THESE

169,APC,BACKGROUND,COPYRIGHT,FGFR1,FGFR2,FURTHER,IRELAND,LABEL,LTD,MET,METHODS,MPM,RESULTS,VHL
006,100,169,216,ACSS1,AFFILIATED,AGA,AGS,BACKGROUND,CCNA1,CHINA,CHINESE,COPYRIGHT,EBV,EPSTEIN,FAM3B,FIRST,GUANGZHOU,IHH,INC,INSTITUTE,INTEGRATED,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SUN,TEN,THESE,TRABD,UNIVERSITY,WALES,WHOLE,YAT
169,945,CONVERSELY,COPYRIGHT,ECH,INC,KEAP1,KELCH,KNOCK,P45,RXR
002,003,004,169,215,930,AUTHORS,BACKGROUND,BLACKWELL,COHORTE,ELY,FENLAND,FRAMINGHAM,HEART,INC,LABEL,LOSMAPIMOD,METABOLIC,METHODS,OBESITY,OVERALL,POPULATION,PUBLISHED,RESULTS,RS2859144,WILEY
169,ATLAS,AUC,BACKGROUND,CALLING,CONSORTIUM,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,ROC,UNIVERSITY,USING,VARIANT,VCF
168,AFTER,CALIFORNIA,FCS,GMM,IL1R2,KNOWLEDGE,LABEL,METHODS,NFKB2,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SETTING,VARIABLES
946,ALONG,EMT,EPITHELIAL,FINALLY,FOS,FRA,NSCLC,PBX,PRE,PREP1,PREVIOUSLY,SMAD3,TGF,THESE
007,016,160,309,310,967,CHINESE,CLEFT,CLPTM1L,HAN,SNP
169,303,405,460,5MG,634,936,ABIGAIL,BOR,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THREE,UNASSIGNED,VEGFR
CHINESE,NSCLC,PCR,SNP
COPYRIGHT,DECISIONDX,HOWEVER,SLACK
009,019,025,029,165,189,262,393,447,464,514,579,586,645,651,704,743,801,873,898,948,953,965,ADDITIONAL,AFTER,BACKGROUND,CCCCC,CONCLUSION,HAPLOTYPES,HAPLOVIEW,HOWEVER,LABEL,METHODS,OCCURRENCE,RESULTS,SEVEN,UNIVARIATE,UTR
169,CONVERSELY,GMX,GMX1777,GMX1778,H1299,NAD,NAMPT,NSCLC,PARPS,PEMETREXED,THESE,USING
177,219,414,741,764,956,ERCC1,LDH,PM2,SALMONELLA,THESE,XPA,XPF,XRCC1,XTT
137,169,COPYRIGHT,HOWEVER,LTD,MRE,TRAIL,WILEY
BACKGROUND,EMBSE,LABEL,MEDLINE,METHODS,NSCLC,RESULTS,WANFANG
CCNE1,THESE,TRITHORAX,ZESTE
166,173,242,249,BACKGROUND,CLINICALLY,HOWEVER,KNOCKDOWN,LABEL,MEIER,METHODS,RESULTS
107,ADAMTS8,APC,BACKGROUND,CDH13,CONCLUSION,DAPK1,GSTP1,LABEL,METHODS,METHYLIGHT,PRIMARY,RESULTS,RFS,SOCS3,WHILE
013,025,038,160,698,ABCB1,ATP,BACKGROUND,GSTP1,III,INHERITED,LABEL,METHODS,RESULTS,SNP,USING
169,945,ANNEXIN,APOPTOTIC,CPG,DMS79,INC,RU486,SMALL,THESE,WILEY
044,177,200,916,COX,HOWEVER,III,NSCLC
946,CPG,RAR
000,AFRICAN,FINALLY,GOVERNMENT,PRESS,PRIOR,PUBLISHED,TEN,UNIVERSITY,USING,WBC,WHITE
169,COPYRIGHT,GADD45A,INC,SEVERAL,TARID,TCF21
169,204,313,399,517,789,AFRICAN,AMERICANS,BLOOD,COPYRIGHT,EVERY,EXOME,HEART,INC,INSTITUTE,MENDELIAN,NBS,PGX,PROJECT,PUBLISHED,SEQUENCING,SOCIETY,THESE
BACKGROUND,BCL,CHINA,FINALLY,GEJIU,HOWEVER,LABEL,NCI,NSCLC,PRINCIPAL,RESULTS,SOUTH,YTMLC
CONVERSELY,KIT,THEIR
001,031,042,131,517,CASES,COX,CURRENT,FACTORS,HOWEVER,LABEL,MARTINI,MELAMED,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS
169,ACIDS,NUCLEIC,PRESS,PUBLISHED,RESULTS,TFS,THEREFORE,THESE,UNIVERSITY
946,EMT,NOTCH,NSCLC,TGF,WESTERN,ZEB
009,099,149,196A2,499,705,ASIAN,INSTITUTE,ISI,MAY,REFERENCES,SCIENCE,SCIENTIFIC,SEVEN,WEB
500,900,916,AMONG,BACKGROUND,BESIDES,CSF,LA1,LABEL,NON,NSCLC,R172H,RESULTS,SINCE
290,522,ASIAN,CIS,ORS,RESULTS,STATA,THERE,USING
BASED,CAUCASIAN,CIS,MEDLINE,ORS,STUDIES
161,169,BIOMARK,COPYRIGHT,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,III,IRELAND,LTD,NSCLC,SNP,XPA,XRCC1,XRCC2
169,COPYRIGHT,DEPENDING,EXOGENOUS,IMPORTANCE,LABEL,OBJECTIVE,ONCOLYTIC,SOCIETY,THEREFORE,UNLABELLED
120,169,495,617,BRCA1,CCND1,CHUNG,CURRENTLY,DDX3X,EPHA2,FGFR1,FGFR2,FGFR3,HNSCC,HPV,KRIGSFELD,LABEL,METHODS,MUTATIONS,NOTCH,OBJECTIVE,PURPOSE,RESULTS,S249C
201,220,277,930,AFTER,DDX58,DEFINITIVE,HOWEVER,III,PRKCE,THREE,VALIDATION
169,346,BECAUSE,COLLEGE,COPYRIGHT,FURTHER,INC,MOLECULAR,PATHOLOGY,PCR,PNA,PUBLISHED,SIX,SOCIETY,THESE
945,946,947,948,949,ACTIVATING,CSC,CUMULATIVE,H1299,NCI,USING,WESTERN
169,181,300,AFTER,BACKGROUND,LABEL,METHODS,MOLECULAR,MULTIGENE,NGS,RESULTS,SOCIETY,SPECIMENS
100,108,169,303,611,BACKGROUND,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,METHODS,PEROXISOME,PPARD,PPARG,PPARS,RESULTS
145,C228T,DESPITE,GENOMIC,NEITHER,PCR,SCC,SMALL
004,007,008,014,411,471,AGE,CAA,CHINESE,NSCLC,UTR
112,946,EPIGENETIC,HOWEVER,III,MSP,PCR,RAR,RASSF1A,SIMILAR,THERE,THESE
524,CHINA,CHINESE,CIS,CLPTM1L,HOWEVER,ORS
100,AD5,ANTITUMOR,CMT,CSF,CTLA4,E1A,E2F,FURTHER,UNDER,VIRUS
106,116,967,ARG,BANGLADESH,HOWEVER,PCR,PRO,SNP
300,DSB,END,GFP,HOMOLOGOUS,JOINING,NON,R26NHEJ,SINCE,USING
160,169,BACKGROUND,CONSORTIUM,COPYRIGHT,IDS,LABEL,LTD,METHODS,MICRORNAS,PUBLISHED,RESULTS,TARGETSCAN,THESE
871,929,954,976,FDG,IHC,LABEL,METHODS,MICRO,OBJECTIVE,PET,RESULTS,THEREFORE
946,ARTHRITIS,BACKGROUND,HEK293T,IFNB1,IL1,IL6,INSTITUTE,INTRAMURAL,JAK,JANUS,LABEL,METHODS,PROGRAM,RESULTS,STAT1,STING,TMEM173,TNF
ADDITIONAL,BACKGROUND,CELLS,EGF,GSPT1,H1650,ID1,INHIBITOR,LABEL,METHODS,NSCLC,PCR,RESULTS,STMN3,THESE,ZBP89
13Q14,169,17Q23,196,471,708,719,779,946,ADULT,AFRICAN,AMERICANS,ASIAN,BLOOD,C5ORF22,ESP,EUROPEANS,EXOME,GH2,HEART,INSTITUTE,MAF,NHLBI,NOTABLY,PRESS,PROJECT,PUBLISHED,SEQUENCING,THESE,UNIVERSITY,USING
000,036,041,215,248,BASED,BETWEEN,CLPTM1L,GOVERNMENT,PRESS,PUBLISHED,UNIVERSITY
001,005,006,154,BACKGROUND,FURTHER,GSTM1,GSTT1,HOWEVER,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TOBACCO
ANN,CARLO,EWING,EWS,FAS,FCGRT,FLI,FNDC5,LABEL,METHODS,MONTE,OBJECTIVE,OLFM1,RESULTS,RHO,RMS,TNNT1,WNT
073,465,APRIL,CAUCASIANS,CBM,ETHNICITY,LIBRARY,MMP,SCHOLAR,SCIENCE,STATA,VERSION,WEB
945,946,EXTENSIVE,IGF
11C,18F,AGENT,DISEASE,FDG,HOWEVER,IMAGING,MICAD,MOLECULAR,PET,PROBE,PROFILING,THEIR,VALIDATED,WEB
107,169,BIOCAST,CFDNA,CONCLUSION,ERBB2,HOWEVER,IONTORRENT,LABEL,MACHINE,MATCHED,METHODS,MULTIPLEX,NGS,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE
195,402,686,716,BACKGROUND,DESPITE,EPAS1,III,IL8RA,LABEL,METHODS,PFS,RESULTS,VHL
ADDITIONAL,AFFYMETRIX,EDC,EPIDERMAL,HNC,HNSCC,LCE3D,PCR,S100A11,SPRRS,THESE
886,954,CPG,FOS,KNOCKDOWN,MYC,PKR,PROTEIN
AFTER,BACKGROUND,CDH13,LABEL,MATERIALS,METHODS,MSP,NSCLC,PATIENT,RASSF1A,RESULTS
002,008,013,240,280,HAPLOTYPE,SNP,TUNISIA,VDR,VITAMIN
802,H1299,NCI,THEREFORE
100,CDC27,EARLY,KRT18,MICROARRAY,NSCLC,PRKDC,VARIOUS
HOWEVER,NGS,PANEL,SNP
BACKGROUND,CIS,CONCLUSION,JANUARY,LABEL,LITERATURE,METHODS,ORS,RESULTS,UNASSIGNED,VIRTUAL
215,249,BACKGROUND,LABEL,ME3,METHODS,NEITHER,RESULTS
011,018,024,028,048,06895,169,456,807,946,AFTER,ANOTHER,FDR,HAPLOTYPE,HSD11B1,INC,NNK,SCC,SNP,THESE,WILEY
001,002,003,052,108,142,146,169,173,183,255,363,581,946,ACADEMY,AGING,BACKGROUND,BLOOD,BPGEN,BRITISH,COHORTS,CONSORTIUM,COPYRIGHT,COUNCIL,DHCR7,FINLAND,FOUNDATION,FUNDING,GENOMIC,HEART,INCREASED,LABEL,LOW,MEDICAL,METHODS,PUBLISHED,RESULTS
100,ADENO,BAF,DCS,EGR,FLT3L,GCV,HCC,HSV,RADIATION,RADIO,THERE,THESE,WESTERN
BACKGROUND,LABEL,MATERIALS,METHODS,MUTATIONS,OSCCS,PCR,RESULTS,SINCE
169,APC,BACKGROUND,CDH13,DELETIONS,LABEL,MBM,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,UNRAVELING
IT1,NSCLC,SPRY4,THESE
182,2DC,HBE,HTB,LABEL,METHODS,MSP,MTT,OBJECTIVE,PCR,PRDM2,PRDM5,RESULTS,WESTERN
169,SOCIETY
DESPITE,EMT,EPITHELIAL,NSCLC,OCCLUDENS,SMALL,SNAI1,SNAI2,SNAIL,TRANSITION
007,013,022,024,047,048,139,AIM,CONCLUSION,COX,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,RESULTS,REV3L,TGT
AD5,CMV,ECS,HOWEVER,MBP,ROBO4,USING,WHILE
132,154,286,AIM,LABEL,METHODS,OBJECTIVE,PAI,PCR,RESULTS
15Q25,169,AMONG,COPYRIGHT,EBLN2,FIRST,GON4L,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NELFE,NOP58,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES,TAF1B,TRUNCATING,WISP3
000,100,298,SCD,SEVERAL,USING
FOXO3,HOWEVER,RRM2B
467,A4T14,CAUCASIAN,CAUCASIANS,CIS,G4C14,ORS
001,004,160,169,171,469,ALK,FINNISH,FURTHER,IHC,INC,MET,NSCLC,SCREENING,SEVEN,WILEY
315,322,673,STRIKINGLY,THESE,THOSE,WGD
001,1A1,926,ASIAN,GSTM1,HOWEVER
ARG194TRP,ARG399GLN,BASED,BIOLOGICAL,CHINA,CHINESE,HOWEVER,KNOWLEDGE,MEDLINE,NSCLC,SIMILARLY,STATA,XRCC1
BACKGROUND,GREEN,GSTP1,LABEL,MATERIALS,METHODS,MSP,NSCLC,PCR,RESULTS,THEREFORE
008,020,028,030,037,156,161,204,244,352,402,478,617,794,934,948,ABCB1,BRCA1,CHINESE,COX,ERCC1,ERCC2,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,XPD,XRCC1,XRCC3
001,020,100,106,143,169,946,967,AMONG,BACKGROUND,COX,LABEL,MEDICAL,METHODS,PC9,PEARSON,PFS,PRESS,PUBLISHED,RESULTS,SMAD3,SOCIETY,TGF,THERE,UNIVARIATE,UNIVERSITY
ALK,AMONG,APRIL,BACKGROUND,BETWEEN,FGFR1,FGFR2,LABEL,MET,METHODS,PLEURAL,RESULTS,RET
109,138,215,259,386,485,532,675,725,BACKGROUND,CHINA,CONCLUSION,LABEL,METHODS,NORTH,RESULTS,SOUTH
945,947,ACTIVATION,BACKGROUND,CONCLUSION,EGR,HOWEVER,JNK,JUN,KIT,LABEL,LUCIFERASE,METHODS,MTT,NSCLC,PEROXISOME,RESULTS,WESTERN
513,BACKGROUND,EPIDERMAL,HOWEVER,L858R,LABEL,METHODS,NORTH,RESULTS,SAMPLES,TTF
139,447,928,CLUSTER,FIFTY,HOXD8,III,LADCS,SPARCL1
168,ALK,CIGARETTE,HOWEVER,MET,SIXTY,SMOKING,THERE
BACKGROUND,CONCLUSION,CURRENT,FITTING,LABEL,METHODS,RESULTS,SNP
169,318,ARID2,PBRM1,SETD2,SMARCA4,SMARCC1,SNF,SWI,THESE
094,160,251,EXPRESSION,HOWEVER,OMNIBUS,TFS,THESE
169,AIG,AMONG,CXCL1,FINALLY,P53
109,ALK,KIRSTEN,SEVERAL,USING
946,954,AKT,EGF,IIA,SECRETORY,THERE
29B,AMONG,COX,MEIER,MYC,NSCLC,RFS,THEREFORE
149,169,ATLAS,EXPRESSION,LARGE,PRESS,PUBLISHED,UNIVERSITY
001,669,983,ASIAN,HOWEVER,SEPTEMBER,SEVENTEEN,SUMMARY
126,169,195,30D,CONVERSELY,PRESS,PUBLISHED,UNIVERSITY
169,946,AUTHORS,CONVERSELY,FOUNDATION,HMG,HOWEVER,JOURNAL,LTD,MOLECULAR,NSCLC,WILEY
169,CHINESE,EMT,FUNCTIONAL,HOWEVER,MUTAGEN,PRESS,PUBLISHED,SNP,SOCIETY,THREE,UNIVERSITY,VEGFR
10Q23,14Q24,16Q11,AFFYMETRIX,CHB,CHINA,CHINESE,CYP2C,HENAN,HOWEVER,IBD,PAIRING,PLCE1,PLINK,SIAH1,SNP,WORLDWIDE
001,040,100,104,147,ACCORDING,AIS,ATS,BAC,BACKGROUND,ERS,IASLC,JANUARY,LABEL,MEDICAL,METHODS,MIA,OSAKA,RESULTS,UNIVERSITY,VIA
169,AUTHORS,BISULPHITE,CHROMATIN,FOUNDATION,JOURNAL,LTD,MOLECULAR,RUNX3,THESE,WILEY
100,BACKGROUND,CELLSEARCH,EPCAM,LABEL,METHODS,RESULTS,SAMPLES,SPIKE,USING
124,523,ALK,ARIZONA,BACKGROUND,CALIFORNIA,CONTEXT,DIEGO,ECHINODERM,IHC,LABEL,MASSARRAY,MEDICAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SAN,SYSTEMS,VENTANA
231,300,BACKGROUND,CLINICALLY,ECTOPIC,EMT,EPITHELIAL,HNSCC,LABEL,MCF,MDA,METHODS,MIR,PCR,RESULTS,TGF,TWIST,UTR
BACKGROUND,D90,GFP,LABEL,METHODS,NDV,NEWCASTLE,PREVIOUSLY,RESULTS
160,200,BACKGROUND,EARLIER,EDU,LABEL,MALIGNANT,METHODS,MPM,PCR,PRIMARY,RESULTS,SILENCING,ZL55SPT
BACKGROUND,CNTNAP2,COX,DSS,LABEL,METHODS,MOLECULAR,PREDICTIVE,RESULTS,TAKEN
047,180,210,390,ACTIVATING,AFTER,AMONG,BACKGROUND,CRC,DETECTION,III,LABEL,METHODS,NSCLC,RELAPSE,RESULTS,WENCA
149,269,335
001,449,512,CHINESE,H1299,HAN,NSCLC,PDCD6,PDCD6IP,TNM
947,ADP,BACKGROUND,CELLS,FANCG,HRR,LABEL,MASSIVELY,METHODS,MPE,NSCLC,PARP1,PARPI,PRIMARY,RAD51,RESULTS
BACKGROUND,CONCLUSION,FINALLY,FOS,LABEL,METHODS,PCR,RESULTS
274,988,CHINESE,CLPTM1L,HOWEVER
001,192,AKT,FURTHER,H3K27,HOX,HOXB7,NSCLC,THESE,TNM,UNIVARIATE
148,BACKGROUND,CASES,FURTHER,GSTM1,GSTT1,LABEL,METHODS,RADON,RESULTS,SEVEN,SIMILAR,THESE
169,947,COPYRIGHT,HDACS,IIA,MYC,REPORTS,YY1
006,122,182,260,275,318,466,733,ACTIONABLE,ALK,AMONG,BACKGROUND,CONSORTIUM,ERBB2,IDENTIFIER,IMPORTANCE,IQR,LABEL,MET,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,SETTING,TARGETING,TRIAL
146,HRM,L858R,MEC,PCR,T790M,TKI
160,ANNEXIN,COCL2,EGR,HRE,INFECTION,MTT,PLASMID,USING
ASP,ASP312ASN,ASP312ASP,CDA,GLN,HOWEVER,LYS,LYS751GLN,NSCLC,THERE,THESE,TTP,XERODERMA,XPD
160,NDRG2,THESE
169,ATLAS,CLOSING,LARGE,PRESS,PUBLISHED,THESE,UNIVERSITY
HDAC1,HOWEVER,LAD,PREVIOUSLY,SP1,TAKEN
105,169,247,269,659,668,727,777,782,793,796,869,880,921,BIOLOGY,INC,MOLECULAR,PKC,PRKCE,SER,SOCIETY,SP1,STAT1
169,200,767,810,ATLAS,EXOME,FINALLY,LABORATORY,PAN,PRESS,PROJECT,PUBLISHED,TRANSPOSEQ
160,169,ANCHORAGE,COPYRIGHT,INC,SHC
229,61A,693,ALLELIC,EGF,ILD,THREE,WHILE
039,040,487,516,AFTER,ATM,BACKGROUND,CHINESE,LABEL,METHODS,RESULTS
734AA,BELARUS,GSTM1,GSTT1,IMBALANCE
169,BACKGROUND,BML,INFERRING,LABEL,LANDSCAPE,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
002,011,027,048,11Q22,707,CASKI,CLASS,HIPPO,LITERATURE,OVERALL,WARTS
214,229,ALK,III,LUNGCARTA,LUNGFUSION,MASSARRAY,MET,MUTATIONS,NSCLC,PANEL,RET,STK11
022,023,031,032,10878,118,123,205,239,255,ADDITIONAL,ALK,BACKGROUND,BUNDANG,DFS,HOWEVER,LABEL,METHODS,MYC,RESULTS,SEOUL,UNIVERSITY
CTC,GENOMIC,INSTEAD,USING
100,159,165,215,369,ATLAS,BACKGROUND,CONCLUSION,CPG,FINALLY,GATA2,HOWEVER,LABEL,METHODS,NNK,NSCLC,RESULTS,SIMILARLY
315,322,673,STRIKINGLY,THESE,THOSE,WGD
169,AFFYMETRIX,INC,USING,WILEY
010,016,022,028,032,040,169,303,AMONG,BACKGROUND,CHINESE,COPYRIGHT,COX,FURTHER,HAN,HORMAD2,LABEL,LOG,LTD,MASSARRAY,MATERIALS,METHODS,NSCLC,RESULTS,SIMILARLY,THESE
169,709,716,CHINESE,COPYRIGHT,CRE,CREB1,HOWEVER,INC,MDR,THESE
946,BACKGROUND,CONCLUSION,CPG,FINALLY,LABEL,METHODS,NSCLC,RAR,RESULTS
001,033,139,169,16Q21,215,946,998,BACKGROUND,COLORECTAL,CSNK2A2,HEART,INC,LABEL,METHODS,OVARIAN,RESULTS,SCREENING,SIKHS,SOUTH,TRIAL,UKCVD
10058,160,ASIAN,JQ1,LIVER,MYC
169
104,169,172,BACKGROUND,DISEASE,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMALL,TKI,WILEY
500,ALDH1,AUC,BMI,CD133,CHINA,CSC,EPCAM,FURTHER,HOWEVER,MUSASHI,ROC,USING
033,266,307,AIM,CHINESE,CONCLUSION,GSTP1,HAN,LABEL,METHODS,MOP,MPO,OBJECTIVE,PCR,PHASE,RESULTS,SNP
378,46T,ARG194TRP,ARG399GLN,BLOOD,ERCC5,GENOMIC,HIS1104ASP,HRS,JANUARY,KIT,NSCLC,PFS,RESULTS,SIMILARLY,XRCC1
169,AUTHORS,BIOLOGY,CELLS,DEPLETION,JAPAN,LTD,MOLECULAR,NSCLC,PTY,PUBLISHING,SOCIETY,WILEY
140,C57BL,CPA,CYPB6TM,E7CD8,EXPRESSION,GDEPT,HPV,NADPH,RED,TC1,THESE
017,043,117,174,334,518,557,681,979,980,BACKGROUND,CHINESE,CLPTM1L,CONCLUSION,LABEL,METHODS,RESULTS,SIMILAR
AGS,H1650,HDAC3,HOWEVER,NCI,STAT3
737,ION,PANEL,SINCE,TORRENT,UNTIL,USING,WHILE
335,371,502,946,DOB,HARVARD,HLA,KLRK1,NSCLC,SNP,UNIVERSITY
BECN1,NON,NSCLC,PACLITAXEL,T24,TXR,UTR
ALK,FIRST,NSCLC
169,COPYRIGHT,HOWEVER,LIVER,PUBLISHED,SAS
104,946,DACH1,DACHSHUND,ED2,KYSE150,KYSE510,NETWORK,PCR,RETINAL,TGF
AFFYMETRIX,CONSISTENT,HOWEVER,MYC,PCR,TAKEN
000,038,229,257,510,522,567,735,952,AFTER,ALA499VAL,ASIAN,BACKGROUND,CAUCASIAN,CIS,CONCLUSION,EGGER,GLN939GLN,HOWEVER,LABEL,LYS939GLN,METHODS,ORS,PAT,PUBLISHED,RESULTS,XERODERMA,XPC
ALK,ANAPLASTIC,BACKGROUND,LABEL,METHODS,MULTIPLEX,RESULTS,SEVERAL,TPR,TRK,TRP
945,AZA,BACKGROUND,BISULFITE,CYP24A1,EXPRESSION,H3K4ME2,H3K9ME2,LABEL,METHODS,NCI,RESULTS,THESE,TREATMENT,TSA,VDR
169,BACKGROUND,CHINA,CONCLUSION,GENOTYPING,GST,GSTM1,GSTT1,LABEL,METHODS,PCR,RESULTS
AKT,AMONG,ERK,HOWEVER,NNK,NOTABLY,STAT3,TRP53
169,HOWEVER,INC,SIMULATION,WILEY
HOWEVER,NOTCH,QKI,SF1,TAKEN
671,BACKGROUND,GENOMIC,LABEL,METHODS,ONCOGENIC,RESULTS,RET
008,009,014,020,022,040,272,544,ARG399GLN,BACKGROUND,GLN,INDIA,LABEL,LYS751GLN,MATERIALS,METHODS,NORTH,RESULTS,XPD,XRCC1
169,483,946,ALCAM,EMT,GDP,RHO,RHOGDI1,SNAIL,WNT
014,150,945,94INS,954,ACCORDING,BIA,HOWEVER,NSCLC,PCR,TURKISH,UTR
169,COPYRIGHT,DNASE,E1B,GENOMIC,PREVIOUSLY,SFN
169,955,HOT,THESE,VCH,WILEY
169,223,411,ALK,BACKGROUND,BETWEEN,CONCURRENT,FGFR1,FGFR2,JANUARY,LABEL,MET,METHODS,RESULTS,RET,SOCIETY,SURGICALLY,THESE
372,ATLAS,AZA,DDP,GDA,ICAM1,LOW,LOXL1,NSCLC,S100P,TEN,TIMP4,TSA,WISP2
AHI,BACKGROUND,EFFECTIVE,FUNCTIONAL,HOWEVER,LABEL,METHODS,NETWORK,OSA,RATIONALE,RESULTS,TREATMENT
1236T,2677T,3435T,AFRICAN,ASIAN,CAUCASIANS,FURTHER,SNP,THERE,THREE
AFTER,MYELOID,RECIPROCAL
169,COPYRIGHT,EPIGENETIC,INC
169,COPYRIGHT,FOLLOWING,H1299,NSCLC,SEGMENT,SP1,SP3,SP4,THEREFORE
001,002,169,564,AFTER,AMERICA,BACKGROUND,CLPTM1L,CONCLUSION,COPYRIGHT,COX,GSV,III,IRELAND,LABEL,LTD,METHODS,NORTH,NSCLC,PFS,RESULTS,STAGE,THESE
169,945,AUTHORS,BECAUSE,LTD,SOMATIC,THOSE,WHETHER,WILEY
169,III,PPB,RNASE,SOMATIC
005,007,009,039,055,169,175,177,30MIN,60MIN,781,798,ATM,BCC,BCT,BTT,COPYRIGHT,DRC,DSR,HOWEVER,MRE11,OLIVE,OTM,RAD50,SSR,XRCC1,XRCC4
BACKGROUND,LABEL,METHODS,NLT,RESULTS,STATA,WANFANG
BACKGROUND,CONCLUSION,H118F,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,S120G,THERE,WESTERN
010,014,127,169,HOWEVER,INC,NSCLC,PCR,SIX,THEREFORE,WILEY
169,191,CA9,CNA,COPYRIGHT,EFT,EWING,HOWEVER,INC,MFH,MUTATIONS,NGS,RUSC2,WILEY
001,027,BIOMEDICAL,CAUCASIANS,CBM,CHINESE,CRUDE,ISSUE,LIBRARY,MEDLINE,NSCLC,SCIENCE,STATA,WEB
FAK,FINALLY,FURTHER,LABEL,LPS,METHODS,NEDD9,OBJECTIVE,PURPOSE,RESULTS
169,ALK,BETWEEN,CONCLUSION,COPYRIGHT,E542K,E545K,E545Q,FGFR1,FGFR2,G719A,GENOMIC,HOWEVER,IRELAND,JANUARY,LABEL,LTD,MATERIALS,MET,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RET,SAMPLES,SCLCS
MMP,THESE
110,OVERALL,PAM50
338,LRP,TMEM205
003,007,048,BACKGROUND,BRMS1,DFI,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,TOWARDS
946,BACKGROUND,C509T,CAUCASIANS,CHINESE,CIS,CONCLUSION,DATABASES,G915C,LABEL,MEDLINE,METHODS,ORS,PNEUMONIA,RADIATION,RESULTS,SEPTEMBER,SUMMARY,T869C,TGF,ULTIMATELY
169,878,945,AML,APL,CONVERSELY,LABEL,LINC00478,MOL,PML,RAR,RARES,RES,RESPONSIVE,THEREFORE,THESE,UNLABELLED
109,119,169,ASIAN,BACKGROUND,BECAUSE,CAUCASIAN,CHINESE,CONCLUSION,COPYRIGHT,FURTHER,IHC,IRELAND,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,PKCIOTA,PUBLISHED,RESULTS,TAKEN
261,ASIAN,CLPTM1L,DUE,LABEL,RESULTS,UNASSIGNED,UNLABELLED
143,196A2,673,CAUCASIANS,CIS,HOWEVER,MICRORNAS,ORS,OVERALL
100,AMONG,CURRENTLY,DETECTION,DUE,KIT,PCR,SEPT9
215,ALK,BACKGROUND,LABEL,METHODS,PTC,RB1,RESULTS,RET,THERE,THESE,TRAPP,WHOLE
EXAMINING,OVERALL,WHILE
169,ARF,ATLAS,CDKN2AB,HOWEVER,INK4A,LABEL,PRIMARY,THESE,UNLABELLED
CEACAM5,MYC,PTBP3,SCC
169,COPYRIGHT,CPSF4,FEDERATION,HOWEVER,MEIER,PUBLISHED,SOCIETIES
169,AFT,INC,SIMULATION,WILEY
771,ASIAN,CIS,FURTHER,IGF,IGFBP,MAY,ORS,STATA
169,CONCLUSION,COPYRIGHT,CYP,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVERAL
169,COPYRIGHT,INC,KRUPPEL,ROS
00128,945,946,CHINA,NPC,THESE
169,954,COPYRIGHT,FEDERATION,PUBLISHED,RAS,RASSF,SOCIETIES
HOWEVER,MICRORNAS,THERE
213,849,ASP353GLU,CBMDISC,CHINESE,CHONGQING,CIS,EGGER,ENGLISH,GLU353ASP,HOWEVER,HWE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,ORS,RESULTS,SCIENCE,TP53BP1,VIP,WEB
183,750,ACTIVATING,AKT,BRAZILIAN,INTER,NSCLC,SCC,SOMATIC,TTF
ASM,ATLAS,DMR,FURTHER,USING
169,BCR,BRITAIN,COPYRIGHT,FGFR1,FGFR2,FGFR3,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
169,600,CADM1,CDH13,DESPITE,EPIGENETIC,FURTHER,HOWEVER,IL4,JAPAN,MEV,MOUSE,MTHFR,PRESS,PUBLISHED,RADIATION,SFRP1,SOCIETY,UNIVERSITY
160,169,AUTHORS,COPYRIGHT,HOWEVER,INC,METASTASIS,PUBLISHED,THESE,TNC,USING
169,946,COPYRIGHT,HBV,HBX,HCC,INC,LINE1,WNT
00069,014,BACKGROUND,CAG,DXS1047,LABEL,LOH,METHODS,RESULTS,SEVENTY,TAIWANESE,XCI
169,ACTIVATING,AIM,CAUCASIAN,DELETIONS,G719X,L861Q,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,POLYMERASE,PTY,PUBLISHING,RESULTS,WILEY
304,585,587,CPG,THESE
231,453,ARV,ATT,CE3,CE9,EXPRESSION,GTT,HEPG2,ILE,LNCAP,MCF,MDA,SEQUENCING,VAL
ATLAS,ATM,BRCA1,ERCC1,HRM,NEIL1,NSCLC,XPC
494,945,COX,HIF1A,HOWEVER,HYPOXIA,NSCLC,RFS,THERE
084,092,304,729,CAUCASIAN,EGGER,GSTP1,ILE105VAL,OVERALL,SCC,ULTIMATELY
169,COPYRIGHT,H3K9ME3,INC,PACLITAXEL,PTX,SUV39H1
BACKGROUND,LABEL,METHODS,POLYGENIC,RESULTS
AMONG,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS
000,169,215,368,736,BLOOD,BONFERRONI,COPYRIGHT,DBP,H19,HLA,INC,MAP,NFAT5,NUCB2,PDE1A,PUBLISHED,SBP,SOCIETY,VCL
003,004,006,026,041,045,2R3RG,2R6,3RG,ACCORDING,NSCLC,PORTUGUESE,SNP
181,NOTABLY,SNP,UTR,WHILE
028,035,152,169,17A,17F,239,258,7488G,CHAIN,COPYRIGHT,HOWEVER,LTD,PCR,POLYMERASE
004,169,370,401,CIS,COLORECTAL,DIETARY,HOWEVER,OVARIAN,PRESS,PUBLISHED,SCREENING,SEVERAL,TRIAL,UNIVERSITY
027,030,239,COX,NSCLC,SEVERAL,SLC29A3,SULT1E1,THREE
487,945,CA2,DAG,IL3,IP3,MYB,PKC,PLC,PROGNOSCAN
954,BAY11,CONVERSELY,GFP,LC3,VAD
008,034,377,CHINESE,GWASS,HAN,HENCE,HOWEVER
169,953,COPYRIGHT,INC,PKC,PRIMARY,PRKCI,PROTEIN
169,363,AMONG,CAUCASIANS,COPYRIGHT,INC,MASSARRAY,NSCLC,PUBLISHED
169,562,741,993,AUTHORS,BRM,LTD,THERE,THESE,WILEY
169,301,441,535,AFTER,COX,EARLY,JOINT,NSCLC,PRESS,PUBLISHED,RESULTS,SNP,UNIVERSITY,WNT,WNT16
121,183,300,CURRENT,NGS,RESTART,THESE,UTILIZING,VARWALKER
384,460,ATM,ATMATRDNA,ATR,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,OIS,RESULTS,RNF43,TELO2,THROUGH
AIM,CONCLUSION,KIRSTEN,LABEL,METHODS,MUTATIONAL,OBJECTIVE,RESULTS,SMALL
00001,001,004,006,169,895,CAD,COPYRIGHT,HOWEVER,MAX,PLEKHG5,PPI,SMAD3,T2D,THESE,TIAM1
005,084,157,169,221,302,554,COPYRIGHT,GWASS,INC,LDL,PCSK9,PUBLISHED,SOCIETY
000,1511G,169,200,208,330,538,AFRICAN,ANGPTL8,ARG504HIS,ARRAY,CHD,COL18A1,COPYRIGHT,EXOME,GLY111ARG,HDL,INC,LDL,LOW,PCSK7,PCSK9,PUBLISHED,SER161LEU,SOCIETY
166,19Q13,676,EGLN2,LTBP4,MASSIVE,SINCE,STRIKINGLY,TGFB1,THESE
946,AZA,BACKGROUND,BASED,CHROMATIN,CPG,HOWEVER,KAISO,LABEL,METHODS,PCR,RESULTS,SPC
FINALLY,FIRST,GIVEN
001,029,050,067,106,202,235,478,893,957,CHINA,EGGER,IL6,KNOWLEDGE,ORS,THEREFORE
169,5A1,954,956,CADMIUM,CDCL2,COPYRIGHT,INC,NOTABLY,SUBSEQUENT,TAKEN,THEREFORE
169,ACE,AUTHORS,BACKGROUND,COMBINING,CONTEXT,COPYRIGHT,ELAC2,FEW,GSTM1,JANUARY,LABEL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,REVIEWERS,SUMMARY,SYNTHESIS,VDR
169,19P,200,205,945,COPYRIGHT,HOWEVER,INC,WILEY
178,319,618,829,837,918,AIM,CEA,CHINESE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,SIXTY
946,954,CHROMATIN,CHRONIC,HBE,NCI,P50
169,ARRAY,AUTHORS,LTD,PCR,PTY,PUBLISHING,SCIENCE,SIX,THESE,WILEY
169,LABEL,MCR,SMALL,UNLABELLED
H3K36,HDAC3,KDM2A,NSCLC,SIMILAR,THESE
169,215,430DUPG,759,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCN,WILEY
ETS,GABPA,HOWEVER,R273H,SEQ,STRIKINGLY
ENBA1,FURTHER,MYC,YET
169,946,ERK,FIBULIN,HOWEVER,MMP,PRESS,PUBLISHED,UNIVERSITY,WNT
169,293,FINALLY,HOWEVER,PCR,SQC
001,159,170,998,ALK,ASIAN,NSCLC,SINCE,VTE
MUTATIONS,NOTABLY,TFE
CJONEDITOR,JOURNAL,NURSING,SELECTION
16HBE,410,766,ARG10,H2126,HOWEVER,NRE,PRE,THESE
945,HIF,HOWEVER,HRE,LNM35,NSCLC,SILENCING,TAKEN,USING
1377G,248,297,844,CHINA,FAS,PCR,SNP,SOUTH
001,002,003,045,208,505,CAUCASIANS,FINALLY,XRCC1
143,DNMT1,H3K9ME2,HBECS,MAL,OLIG2
169,946,ANGIOMOTIN,COPYRIGHT,HOWEVER,INC,SRSF1,TAKEN,TCF,YAP,YES
34A,THESE,UTR
23A,27A,BACKGROUND,BISULFITE,CONCLUSION,EPIGENETIC,LABEL,MET,METHODS,MPM,PCR,RESULTS
CURRENTLY,FDA,GUIDELINES,MUTATIONAL,NSCLC
AFTER,AIM,ANNOTATION,ARCHIVE,BASED,CUFFLINKS,EXPRESSION,FCGBP,GSM718709,GSM718710,KOBAS,LABEL,MATERIALS,METHODS,OBJECTIVE,OMNIBUS,ORTHOLOGY,RESULTS,SRA,THESE
AKT,BIM,FOXO1,H1299,JNK,MTT,NUCLEAR,THESE,USING
190,214,FGFR3,INCREASED,LCS,PCR,R248C,R248H,R273C,TACC3
107,137,375,CPG,MICRORNAS,NSCLC,PCR
ADPGK,ALDOA,ATP,GAPDH,GLYCOLYSIS,GPI,HK1,PCR
169,560,ATP,EHF,LABEL,MOL,NSCLC,RES,SMARCA4,SNF,SWI,UNLABELLED
169,336,977,ALK,CHINESE,CONCLUSION,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,TEN,TKI,WESTERN
001,149,332,ALK,L858R,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
3KT,DNMT1,FINALLY,HDAC1,HDAC2,HDAC3,HDACS,SFRP2,TARGETING,THESE,TREATMENT,VPA
169,183,215,AAV,BACKGROUND,CHM,COPYRIGHT,DEPARTMENT,DESPITE,FUNDING,LABEL,LTD,MAXIMAL,METHODS,RAB,RESULTS,THESE,TRUST
IIA,SCC,SEVEN
148,327,ASA,DUE,PCR,SER326CYS,SIMILARLY
169,BASEL,BIOLOGICAL,HOWEVER,USING
BMPR2,BRCA1,ECS,OCCLUSIVE,PAH
169,COPYRIGHT,DESPITE,LTD,NON,ONCOGENES,THROUGH
001,039,040,552,602,HOWEVER,NSCLC,TELOMERASE,THESE
169,945,946,BAIBA,COPYRIGHT,INC,PGC
947,CD4,CD8,FAS,HUPBL,MHC,NOD,STAT1,VEGFR
001,011,015,024,028,030,046,164,CCTTT,GENOTYPES
154,169,489,CSNK1A1,FN1,KNOCKDOWN,LOW,MACC1,NBN,NFAT5,NOTABLY,PCR,SOX17,SRY,USING
169,617,946,FINALLY,KNOCKDOWN,LTD,OVERALL,PATHWAY,PKC,PUBLISHED,TAKEN,WILEY
150,AIM,CONCLUSION,FIFTY,FOLFIRI,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TREATMENT
169,231,DDR,ECTOPIC,EMT,H1299,KNOCKDOWN,MDA,PRESS,PUBLISHED,SENESCENCE,TAKEN,UNIVERSITY
160,169,AUTHORS,BPH,DU145,GLEASON,LNCAP,LTD,PC3,PCR,PEARSON,PSA,TNM,WILEY
FUNCTIONAL,IVS,MIB,SDH
001,110,122,169,AFTER,AMONG,CPEB1,EMILIN2,KNOCKDOWN,PRESS,PUBLISHED,ROBO3,STAGE,STUDIES,UNIVERSITY
MES,PCR,PRDM5,TAKEN,WESTERN
169,INC,SIMULATION,WILEY
BMP,HOWEVER,TIE
001,169,CONCLUSION,COPYRIGHT,III,IRELAND,LABEL,LTD,METHODS,MSP,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TET,THERE,THEREFORE
169,ALK,BACKGROUND,BETWEEN,COPYRIGHT,JANUARY,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY
026,031,114,129,290,355,392,479,558,624,625,635,726,734,740,753,782,786,860,897,908,910,972,978,BACKGROUND,CHINESE,CLPTM1L,HAN,HOWEVER,LABEL,METHODS,RESULTS
140,AFTER,ANTIGEN,CARCINOMA,CEA,CEACAM5,CONCLUSION,GASTRIN,GMP,GRANULE,GRP,KRT,KRT19,LABEL,METHODS,OBJECTIVE,PEPTIDE,PROTEIN,RELEASING,RESULTS,SFTPB
019,032,074,096,159,164,173,199,221,366,409,502,517,579,580,809,816,825,870,933,CHINESE,HAN,NSCLC,SIMILAR,SNP,THEREFORE,UTR
001,002,003,007,PRO,STATE,T309G
HOWEVER,USUALLY
169,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,INC,KIRSTEN,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,TESTING,THERE
BACKGROUND,CHINA,CIS,LABEL,METHODS,ORS,RESULTS,SNP,TAIYUAN,VARIANT
170,BACKGROUND,CONCLUSION,CPG,EPIGENETIC,FOXG1,GRIK3,HAND2,HLA,HOX,III,LABEL,NEUROG1,PATHWAY,PRKCB,PTGDR,RAP1A,RESULTS,STAGE,UBC
169,194,280,312,399,751,CAUCASIANS,COPYRIGHT,ERCC2,HOWEVER,LABEL,LYS751GLN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SCIENCE,STATA,THREE,WEB,XPD,XRCC1
FINALLY,MAX,MGA,MYC,SNF,SWI
169,241,COPYRIGHT,CPG,PCR,PORTUGUESA,PUBLISHED,SOCIEDADE,TNM
001,009,160,190,382,572,AHR,ARG,BACKGROUND,CCND1,EPHX1,ILE,LABEL,LYS,MESTIZO,METHODS,MEXICAN,RESULTS,STUDENT,TYR,VAL
169,954,ASSAY,AZA,BACKGROUND,BASEL,H1703,H1915,H1975,H1993,H2073,LABEL,MCL,METHODS,MICRORNAS,MTT,NCI,NSCLC,PCR,PDT,RESULTS,TREATMENT,WESTERN
ABSENCE,ANTICANCER,K292E,NCI,PUBLISHED,TYROSYL
013,072,077,353TT,791,940,BACKGROUND,EMT,EPITHELIAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SEVEN,SNAI1,THERE,VAL118ALA
240,947,BACKGROUND,CCDC6,CONCLUSION,HODKGIN,KIF5B,LABEL,METHODS,NCOA4,RESULTS,RET
134,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,RESULTS,RET
169,293,GREEN,H1299,INC,NSCLC,POLYPHENON,TAM67,WILEY
BESIDES,FUNCTIONAL,LABEL,MATERIALS,METHODS,MICROARRAY,OBJECTIVE,OBJECTIVES,PROTEIN,REFERENCE,RESULTS
142,537,BESIDES,CLUSTER,CONCLUSION,DAVID,EXPRESSION,FUNCTIONAL,GENECODIS,GSE3268,LABEL,MATERIALS,METHODS,MIR,OBJECTIVE,OMNIBUS,RESULTS,SLC,THESE,WEBGESTALT
040,045,15Q25,200,210,ADDITIONAL,CAUCASIANS,CHINESE,HAN,HOWEVER
162,169,311,430,741,945,A588T,AIM,BASEL,CONCLUSION,HIF,LABEL,METHODS,NSCLC,OBJECTIVE,P582S,PFS,RESULTS
169,BECAUSE,CPG,HTB56,LABEL,METASTASIS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,WIDESPREAD
169,BESIDES,COPYRIGHT,HOWEVER,PDCD4,PROGRAMMED
169,COPYRIGHT,INC,NOTCH,RBM10
22Q13,BACKGROUND,BRCA1,LABEL,PPP2R2A,PRKDC,RESULTS
104,261,CONCLUSION,CURRENTLY,FGFR3,KEAP1,LABEL,METHODS,NORTH,OBJECTIVE,PURPOSE,RB1,RESULTS,SCC,SEVEN,TACC3,THESE
USING
12QF1,ACTIVATION,APOBEC1,GNAO1,PRKG1,TAKEN,THESE
GMP,MOUSE,PDE
000,013,030,039,103,105,191,197,224,300,332,376,413,441,719,744,776,809,831,832,834,844,849,862,882,893,902,958,959,962,968,ASIAN,HOWEVER,IGFBP,INSULIN
169,AUTHORS,BRITAIN,CRE,FOLLOWING,GEM,GIVEN,GREAT,IRELAND,JOURNAL,LTD,PATHOLOGY,SOCIETY,WILEY
FGFR1,HOWEVER,LABEL,MYC,UNLABELLED
ABC,ABCC4,H1993,H2073,MET,SNP,STK11,WHILE
000,298,ASSISTANT,BATCH,LUNGCAGXE
169,190,945,COPYRIGHT,HIF,SAR,THEREFORE,VCH,WILEY
169,207,218,516,525,532,539,598,604,755,769,946,954,CAM,EBP,FUS,MMP,MUTATIONAL,SW872
001,102,117,BACKGROUND,BETWEEN,ERMETIC,INSTITUTE,L858R,LABEL,METHODS,NSCLC,RESULTS,THERE,UNDER
00010,035,039,BACKGROUND,CONCLUSION,CONTEXT,HGNEC,LABEL,METHODS,OBJECTIVE,RESULTS
540,FINALLY,LSL,NSCLC,RAS,SCRIB
127,201,322,337,399,558,CAUCASIANS
169,180,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,EBC,IRELAND,LABEL,LTD,METHODS,MSP,NON,NSCLC,P16,PUBLISHED,RESULTS
005,009,193,298,324,961,AZA,BACKGROUND,CPG,EXOGENOUS,H23,HRM,LABEL,NSCLC,PRINCIPAL,RESULTS
111,152,267,433,586,AFFYMETRIX,AGILENT,ATLAS,FINALLY,NON,PCR,PROTEIN,RAF
028,160,1772C,1790G,945,BACKGROUND,CAUCASIANS,HIF,LABEL,PRINCIPAL,RESULTS
013,016,025,028,539,627,ASIAN,BACKGROUND,CAUCASIANS,CHINESE,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
002,218,317,AZA,H23,NSCLC,TRANSIENT
1195G,247,271,956,994,ACADEMY,AMONG,CHINESE,CONCLUSION,HAN,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SCIENCE,THERE,TOTALLY,WHILE
ASIDE,EPIGENETIC
169,COPYRIGHT,LTD,MICRORNAS
169,8505C,8505CBRAF,956,AZA,BACKGROUND,BCPAP,BRAFV600E,CONCLUSION,COPYRIGHT,CPG,DAC,EXPRESSION,INC,LABEL,LATER,MAGEA,MEK,METHODS,MOSBY,PLX,PLX4720,RESULTS,TPC,TREATMENT
EPIGENETIC,RIGHT
BAC,CAREFUL,CONGENITAL,POLYMERASE,THEREFORE,THESE
001,27A,576,BACKGROUND,CHINESE,CONCLUSION,COX,FURTHER,LABEL,LOG,METHODS,NSCLC,RESULTS,SNP
00099,001,169,215,945,BACKGROUND,CDC53,CONCLUSION,COPYRIGHT,DIEGO,HAPLOTYPE,INC,LABEL,MACROPHAGE,METHODS,MIF,NSCLC,RESULTS,SAN,SCF
169,176,956,BACKGROUND,CONCLUSION,DUE,GENOMIC,INC,LABEL,METHODS,MGCL2,PCR,POLYMERASE,RESULTS,WILEY
169,COPYRIGHT,DUE,ERK,FLOTILLIN,FLOTILLINS,HOWEVER,INC,INCREASED,THESE
443,BACKGROUND,ELISA,LABEL,METHODS,NSCLC,OPN,PCR,RESULTS,SERUM,SNP,THERE
954,ACTIVATING,FOXM1,IKBKB,JNK,JUN,MYC,NFKB1,NFKB2,PTTG1,RAS,SFTPC,TRANSGENIC
169,215,500,COPYRIGHT,FINALLY,INC,MOLECULAR,NGS,PATHOLOGY,PUBLISHED,SOCIETY,TOOLKIT
130,240,878,946,BACKGROUND,CANCERS,CONCLUSION,LABEL,METHODS,RESULTS,SIRNA,THESE,WNT,WNT3A
113,12P12,134,16P,192,210,21Q,309,413,457,914,BACKGROUND,GENOMIC,LABEL,METHODS,RESULTS,SEVERAL,SUPERVISED
215,AFTER,CHINESE,FURTHER,HOWEVER,LABEL,PPP2R1A,PPP2R1B,PPP2R2A,PPP2R2B,PPP2R5C,PPP2R5E,PROTEIN,SNP,UNASSIGNED,UNLABELLED
DUSP3,EPIGENETIC,H3K36,HISTONE,KDM2A,NSCLC,THESE
HCC,HDAC5,HOWEVER,MES,PTP,PTP1E,PTPL1,PTPLE,STAT3,USING
004,017,018,023,032,034,169,AOI,AOS,INC,THERE,THESE,WILEY
953,ERK,FINALLY,GENOMIC,HOWEVER,LABEL,MEK,PKC,PROTEIN,THESE,TIC,UNLABELLED
169,CCCTC,CHROMATIN,CHROMOSOME,DEPLETION,TELOMERASE
LRP,MAJOR,MVP,SP1,SW620,THESE,USF,USING
ADCY2,ADCY9,APC,COLORECTAL,HDAC6,ION,JAZF1,METASTASIS,PGM,SIGNALING,TORRENT,WHOLE
169,375,AEG,HOWEVER,IGF1R,MICRORNAS,MIR,REDUCED
BACKGROUND,CONCLUSION,CONTACT,FURTHER,HKDC1,LABEL,MOTIVATION,OWING,RESULTS
946,AKT,CPG,ECTOPIC,THROUGH,TSG,WNT,WNT5A
008,149,300,967,BACKGROUND,BESIDES,CONCLUSION,HOWEVER,LABEL,METHODS,PCR,PEARSON,RESULTS,THERE
GPCRS,GPR65,H1299,INSTEAD,MYC,TDAG8
001,007,031,192,502,576,BACKGROUND,CONCLUSION,FUNCTIONS,FURTHER,LABEL,LOG,LOWER,LUCIFERASE,METHODS,NSCLC,RESULTS,SET,USING
GATEWAY,USING
MITOSIS,NSCLC,SGOL1,SHUGOSHIN,THESE
001,169,954,BACKGROUND,LABEL,METHODS,MICRORNAS,MIR,RESULTS,THESE
HOWEVER,MMP,MTT,THEREFORE,TRANSWELL
004,005,006,169,19Q13,339,358,772KB,BACKGROUND,CD3EA,CHINESE,CHROMOSOME,COPYRIGHT,ERCC1,ERCC2,LABEL,LTD,MDR,METHODS,PPP1R13,RESULTS,SNP
169,AUTHORS,COPYRIGHT,H3K27,INC,PUBLISHED,REDUCTION
058,169,379,462,945,946,COPYRIGHT,CRP,IL6,LTD,MPO,THERE,THEREFORE
169,AFTER,CONCLUSION,COPYRIGHT,GEFITINIB,H1703,IRELAND,LABEL,LTD,MATERIALS,METFORMIN,METHODS,MKK6E,MTS,OBJECTIVE,OBJECTIVES,PCR,PROTEIN,RESULTS,TRANSIENT,WESTERN
HOWEVER,NSCLC,SIMILARLY
A2A,A2B,FINALLY,JUN,LEWIS,LLC,USING
BURKITT,C57BL,COX,DLBCL,FOXM1,MYC
140,169,34B,ECTOPIC,EPIGENETIC,EXPRESSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
2B7,ADDITIONAL,ALTERNATE,ASE,CONCLUSION,LABEL,MATERIALS,METHODS,NOVEL,OBJECTIVE,RESULTS,THESE,UDP,UGT2B7S
169,ACCORDING,COLLEGE,COPYRIGHT,CRUDE,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,OVERALL,PROQEST,PUBLISHED,RESULTS,ROYAL,SCIENCE,SMOKERS,WEB
124,BACKGROUND,FOXO3,LABEL,METHODS,OBJECTIVE,PULMONARY,RATIONALE,RESULTS
DGIDB
169,ACTIVATING,ALK,AUTHORS,BRITAIN,FGFR1,GREAT,IRELAND,JOURNAL,LTD,MEK,MET,NSCLC,PATHOLOGY,RET,SOCIETY,THESE,WILEY
198,SNP,THESE
054,057,060,064,100,104,201,230,238,308,BACKGROUND,LABEL,LC1,LC2,METHODS,NSCLC,RESULTS,SIMILAR,TNF
CHECKPOINT,CHEK2,I157T,LOW,MEDICAL,MUTATIONS,STUDIES
CROSS,EYA4S,NSCLC,TSG
009,014,031,309,310,CHINA,CURRENT,HAN,OVERALL,SNP
024,037,047,11P15,12Q23,160,16Q22,967,COMMITTEE,FAL,FRACTIONAL,III,JOINT,KRUSKAL,LOH,MSI,NSCLC,STAGING,THESE,TOTAL
001,009,014,019,027,035,048,ASIAN,BACKGROUND,CAUCASIAN,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,THESE
160,970,BACKGROUND,CONCLUSION,HOWEVER,ISI,LABEL,METHODS,MSP,NSCLC,POTENTIAL,RESULTS,SCIENCE,WEB
106,116,271,706,BANGLADESH,CHAIN,INDIVIDUAL,POLYMERASE,THEREFORE
BACKGROUND,CAARRAY,CONCLUSION,DNMT2,EPIGENETIC,GEO,HDAC4,HIGHEST,LABEL,METHODS,RESULTS,SIGNATURES,SIRT1,TGF,USING
002,003,006,010,168,169,199,200,259,317,860,875,885,902,933,AKT,COX,FRAP1,HRS,LABEL,MEIER,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SNP
000,AUTOSOMAL,BECAUSE,E8SJM,GIVEN,LABEL,LDLRAP1,MENDELIAN,OBJECTIVE,RESULTS
BESIDES,CIS,HOWEVER,ORS,VDR
2O2,BASED,DESPITE
002,022,123,1394T,142,487,501,643,842,CHINESE,CONCLUSION,G135C,LABEL,METHODS,OBJECTIVE,PCR,RAD51,RESULTS,XRCC4
169,CHINA,COPYRIGHT,G719X,GIVEN,L858R,LTD,XUANWEI
169,883,AMONG,COPYRIGHT,FINALLY,INC,PATHOLOGY,PCR,PUBLISHED,SOCIETY,WHSC1L1
056,682,841,945,C111A,CHINA,FURTHER,HIF,HOWEVER,KNOWLEDGE,OVERALL,THEREFORE
19Q13,CPD,EGLN2,THESE
ADC,CALM1P2,HOXA4,HOXA5,HOXA6,HOXA7,HOXA9,LOC442282,LOC442586,LOC442589,LOC442651,MBP,NOTABLY,VARIATIONS
113,118,125,140,204,251,A743V,L718M,L815P,NSCLC,PCR,V819E
021,147,216,387,700,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNP
169,ARISTALESS,BCL,CPG,HOWEVER,PCR,THESE,USING,WESTERN
USING,UTR
AGC,AKT,GSK2334470,NOTABLY,PKC,SELECTIVE,V600E
ACTIVATION,AKT,C57BL,ERK,FAK,FVB,HOWEVER,MGAT3,POLYOMA,PREVIOUSLY,SRC,TEC
160,603,657,AFTER,APOC1,CIS,COX,CRP,GRS,HNF1A,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
153,737,ABT,BAD,BCL2L11,BIM,COR,DMS,L42,NEITHER,NOVEL,SMALL
169,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,EPIDERMAL,LABEL,METHODS,NSCLC,PUBLISHED,SAS,T790M,TKI
007,032,058,ASSESSMENT,BACKGROUND,DIETARY,HARVARD,HISPANICS,HOWEVER,LABEL,METHODS,NAA,NHW,OBJECTIVE,OBJECTIVES,OVERALL,RATIONALE,RESULTS,SMOKERS,SMOKING,UNIVERSITY
169,555,600,COPYRIGHT,INC,KIT,KITLG,LCNEC,PCR,POSITIVITY,SCF,WILEY
169,224,448,954,BESIDES,CHINA,CHINESE,COPYRIGHT,HAPLOTYPE,LABEL,LTD,METHODS,OBJECTIVE,POL,PURPOSE,RESULTS,TLS
160,169,674,CONVERSELY,COPYRIGHT,HOWEVER,INC,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY
169,231,ETS,HGF,MDA,ORF
001,127,326,843,AGS,BACKGROUND,BINDING,LABEL,METASTASIS,METHODS,RESULTS,SGC,SP1,TNM
100,563,607,898,BACKGROUND,FURTHER,GENOMIC,LABEL,MALAY,METHODS,PRINCIPAL,RESULTS,THESE
100,946,AZA,HOWEVER,MTS,PCR,TNM,TREATMENT
AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TRANSGENIC,WESTERN
ABC,ABCG2,ATP,BINDING,KNOCKDOWN,SP1,SP3
169,COPYRIGHT,EXPRESSION,INC,NSCLC,PCR
2578C,676,861,CAUCASIANS,CBM,CIS,CRUDE,HOWEVER,LIBRARY,MAY,ORS,SCC,SCIENCE,WEB
ASIAN,FURTHER,HOWEVER,OVERALL
169,EMT,F191G,FINALLY,HOXA9,LABEL,STRUCTURE,TARGETING,THEREFORE,THESE,TWIST,UNLABELLED
E2F,LENTIVIRAL
EPIGENETIC,FINALLY,HOWEVER,RUNX3,SLIT3,THESE,UHRF1,UTR
BACKGROUND,BAYES,COLON,CONCLUSION,FEATURE,ITERATIVE,LABEL,MACHINE,MULTI,NAIVE,NCI,RECURSIVE,RESULTS,RFE,SUPPORT,SVM
169,22YEARS,COPYRIGHT,IRELAND,LTD,P53,SEQUENCING,THESE,V157D
022,023,029,313,728,CAUCASIANS,CIS,G463A,MPO,ORS,OVERALL,SIMILAR,STRATIFIED,WANFANG
169,362,405,411,491,583,909,BOS,KANKREJ,NUCLEOTIDE,PCR,SCC,SNP,VALIDATION
204,215,688,CNTNAP1,COX,FAM156A,FRMD8,GALNTL1,SEQ,SNTB1,SNX10,TEN,THESE,TXNDC12
005,007,010,016,017,027,036,038,043,242,BCL,CHINESE,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THREE,UTR
581,THERE,TRUNCATING,WHOLE
BAC,BACKGROUND,COX,GINS3,LABEL,MEIER,METHODS,MSP,MTS,PCR,PFS,RESULTS,S100P,TGFB3,WOUND
EVALUATION,MALIGNANT,MPM,PCR
169,AXL,COPYRIGHT,CROSSTALK,LTD,MED12,NON,THR790MET
231,BACKGROUND,IDC,IMAGING,LABEL,MDA,METHODS,MSP,PCR,PRE,PRKD1,RESULTS,USING
FOXO1,FOXO3,NOTABLY
CLINICALLY,H19,H3K9ME3,MINERAL,SILENCING,TAKEN
948,AKT,CCAAT,EBP,ERK,EXPRESSION,HOWEVER,LEP,MEK,NRF,STAT3
111IN,CMV,DOTAP,GAMMA,NSCLC,SPECT,SSTR2,TUSC2,WESTERN
169,CARLO,FINALLY,GORFINE,HOEFFDING,KENDALL,MONTE,PEARSON,PRESS,PUBLISHED,SYSTEMATIC,UNIVERSITY
169,AD5,CAR,H2052,HOWEVER,NCI,ONCOLYTIC
001,003,045,279,326,410,ADPRT,ASP148GLU,BACKGROUND,CHINESE,CYS,LABEL,METHODS,RESULTS,SER,SER326CYS,THREE,VAL762ALA
009,031,169,233,AFTER,ATLAS,LABEL,MARKERS,METHODS,MIR,NOTABLY,OBJECTIVE,PCR,PURPOSE,RESULTS
159,BACKGROUND,H1568,H1650,LABEL,METHODS,NSCLC,RESULTS,VIA,WILMS,WOUND,WT1
11047,169,275,ECH,KEAP1
ASIAN,CAUCASIAN,HOWEVER,MPO
399,AFRICAN,ASIAN,CAUCASIAN,CHINESE,HOWEVER,ORS,XRCC1
BACKGROUND,CONCLUSION,LABEL,METHODS,PCG,RESULTS
144,AFTER,BACKGROUND,COMPARING,HOWEVER,INTERFERON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THERE
072,099,112,198,356,509,539,618,651,710,939,960,BACKGROUND,LABEL,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,THR241MET,XRCC3
INDUCED,INTRACRINE,LOCALLY,PITUITARY,PREMATURE
169,29A,29B,29C,29S,946,COPYRIGHT,DNMT1,DNMTS,HOWEVER,INC,MIR,NSCLC,PCR,TAKEN,WESTERN,WIF,WNT
AFRICAN,AMERICANS,BACKGROUND,CONCLUSION,CONTEXT,FIRST,HISPANICS,HOWEVER,LABEL,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SAMPLES,SMOKING
49A,CYTOTOXIC,HOWEVER,NSCLC,PCR
945,954,HOWEVER,HSP70,SIMILAR,TNF
002,009,045,1239C,1239G,2E1,526,CHINESE,CYTOCHROME,HOWEVER,ORS,TNM
006,018,946,BIOMARKERS,COL11A1,ETS,MICROARRAY,PCR,SMALL,TGF
169,COPYRIGHT,DZNEP,H3K4ME3,H3K9ME3,HMTASES,INC,PCR,REDUCED,SUV39H1
ACTIVATING,ALK,AREAS,BACKGROUND,COVERED,FGFR1,LABEL,MET,METHODS,NSCLC,ONCOGENIC,OPINION,RET,SCC,SEVERAL
HOSPITALS,HOWEVER,NSCLC,THESE,UNIVERSITY
001,024,113,139,147,150,160,AIM,ALA,ARG,BACKGROUND,ETS,EXONS,GENOTYPING,HOWEVER,LABEL,METHODS,MNSOD,OBJECTIVE,RESULTS,TYR,VAL
507,662,CHINESE,ETS,HAN,NSCLC,XRCC3,XRCC4
ATTENUATED,SALMONELLA,THEREFORE
169,775,EMP,EPITHELIAL,HOWEVER,INC,NSCLC,TNM,WHILE
169,COPYRIGHT,CROWN,ECTOPIC,H1299,HOWEVER,INC,PUBLISHED,TAKEN,TSA,USING
169,BACKGROUND,FUNCTIONAL,GENERAL,LABEL,MAPK1,METHODS,MIR,PCR,RESULTS,SNAI2,WESTERN
169,BAYES,CPG,EUCLIDEAN,LTD,PUBLISHED
AEROSOL,FINALLY,SEVERAL,THEREFORE
A870G,CCND1,HOWEVER,PCR,THERE
897,904,AIM,BONFERRONI,CDP,GTPASES,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,RHO,SIX
DESPITE,EHMES,IGF,MPM,NCI,PAPPA
100,169,287,AMONG,BACKGROUND,FNA,GENOMIC,HISEQ,LABEL,METHODS,NOS,NSCLC,RB1,RESULTS,SCLCS,SMAD4,SOCIETY
169,215,219,226,871,882,BAYES,CONSORTIUM,EHB,EPIDEMIOL,GENET,GWASS,INC,INFERENCES,MURCRAY,THESE,WILEY
008,230,299,463GA,MPO,SP1
AKT,CMTM6,CMTM7,CPG,ECTOPIC,TSG
169,COPYRIGHT,HOWEVER,IRELAND,LTD,MUTATIONS
00001,169,904,ADC,AIS,ATS,BACKGROUND,COPYRIGHT,COX,EPIDERMAL,ERS,IASLC,IDI,IRELAND,LABEL,LEPIDIC,LTD,METHODS,MIA,RESULTS,SOCIETY
160,CATALAN,EXPERTS,FIRST,GERMANY,HEIDELBERG,IMPPC,MEDICAL
443,CHI,CONCLUSION,III,LABEL,MEIER,METHODS,OBJECTIVE,OPN,PURPOSE,RESULTS,THREE,TNM
144,169,16Q12,423,AMONG,AUTHORS,BRITAIN,CHINA,EBF,EBV,EPSTEIN,GREAT,IRELAND,JOURNAL,KNOCK,LTD,NOTABLY,NPC,PATHOLOGY,SOCIETY,THESE,WILEY
004,005,006,009,803,819,BACKGROUND,CHINA,CHINESE,FURTHER,GENOTYPES,GIVEN,HAN,HAPLOTYPE,HARDY,LABEL,MDR,METHODS,OVERALL,PALLELE,PGENOTYPE,QIQIHAR,RESULTS
103,169,ALK,BRM,FGFR1,HOWEVER,NSCLC,SMARCA2,SMARCA4,SNF,SWI
15Q25,EMSAS,PUBLISHED,RESULTS,SNP
BESIDES,DESPITE,EARLY
15A,921,BCL,DLEU2,FINALLY,HDAC3,HDACS,HISTONE,HOWEVER,THEREFORE,TSA
000,001,002,160,BACKGROUND,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,POPULATION,PULMONARY,RESULTS
945,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LUCIFERASE,METHODS,MTT,NAC,NSCLC,RESULTS,SILENCING,SMALL,TRANSIENT,WESTERN,WHILE
001,288,ASIAN,BACKGROUND,CAUCASIAN,HOWEVER,LABEL,MARCH,MEDLINE,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE
169,ACTIVATION,PRESS,THESE
205,954,AKT,CONVERSELY,HOWEVER,NSCLC,PHLPP,TAKEN
001,002,003,008,009,104,107,108,122,145,154,160,177,520,655,689,768,945,946,BCL,CLASS,CONCLUSION,ERCC1,III,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PCR,RESULTS,TARGETING,WESTERN
169,BOX,COPYRIGHT,EMT,FOXM1,IRELAND,KNOCKDOWN,LTD
1A1,945,946,AHR,CYP,INCREASING,WHEREAS
763,ACCORDING,AIM,BACKGROUND,CUFFLINKS,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SHANNON,THESE
431,ALF,ASP,CNS,EXPRESS,L858R,PCR
183,196,31C,599,ARG,GLU,LABEL,LYS,MET,METHODS,OBJECTIVE,PPI,PTGS2,PURPOSE,RESULTS,SYMPTOM,TNFR2,USING
169,ASXL1,BRCA1,COPYRIGHT,DESPITE,DROSOPHILA,H2B,HOX,INC,P19,UCH
169,450,FANCC,FANCONI,MICROARRAY,THESE
169,COPYRIGHT,CXCR4,INC,METASTASES,METASTASIS,OSTERIX,RANKL,RB1
BACKGROUND,DEL,FGFR1,FINALLY,GEFITINIB,HOWEVER,LABEL,METHODS,NSCLC,PATIENT,RESULTS,TEN
689,CAUCASIANS,ILE,ULTIMATELY,VAL
003,004,169,170,225,COPYRIGHT,INC,NSCLC,PCR,PUBLISHED,SOCIETY
114,229,308,386,389,611,614,945,AIM,BACKGROUND,CONCLUSION,GASTRIC,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TNF
169,203,367,392,428,508,778,ADDITIONAL,AUSTRALIA,AUSTRALIAN,COPYRIGHT,CRTAM,HOWEVER,IRELAND,ITALIAN,ITALY,LTD,MALIGNANT,PUBLISHED,RASGRF2,THESE,WESTERN
004,109,140,230,674,BACKGROUND,BANGKOK,CONCLUSION,DESPITE,FURTHER,LABEL,LYMPH,METHODS,NODAL,NSCLC,RESULTS,SHP
HOWEVER,JNK,LRP,MAJOR,MVP,SP1,SW620,THEREFORE,UNDER
201,92A,BACKGROUND,CONCLUSION,CONVERSELY,GELATIN,H1299,LABEL,LUCIFERASE,METHODS,MMP,PCR,PROTEIN,RESULTS,S3I,STAT3,TRANSWELL,UTR
215,BACKGROUND,E2F,KNOCKDOWN,LABEL,LIVER,LXR,METHODS,PCR,PUBLISHED,RESULTS,TAKEN
172,1ST,289,2ND,CONTROL,EH3,EH4,EXB,HARDY,MAYAK,PHASE,THERE,TYR113HIS
013,215,CHINESE,MITOGEN
154,DECREASED,FURTHER,NSCLC,PCR,THEREFORE
003,215,451,694,696,935,AMONG,BPI,CIS,COLORECTAL,INHERITED,ITGB2,LBP,MYD88,ORS,OTHER,OVARIAN,SCREENING,SIXTEEN,TRIAL
AFRICAN,ALK,AMERICANS,BACKGROUND,BIOMARKER,CALIFORNIA,CONTEXT,DIEGO,HOWEVER,LABEL,MET,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SAN,STAT3,TARGETABLE
169,BACKGROUND,BISULFITE,CHROMATIN,COPYRIGHT,CPG,EPIGENETIC,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RUNX3,SOCIETY,THERAPY,THESE
PAX3C,PAX3D,PAX3E,TAKEN,WHILE
120,169,ASP148GLU,CERTAIN,EPHX1,HIS139ARG,INC,NAD,PRO187SER,WILEY
100,169,200,233,245,445,ASIAN,AUTHORS,BACKGROUND,BASED,CURRENTLY,L858R,LABEL,METHODS,OBJECTIVE,PACIFIC,PCR,RESULTS,SCREENING,SOCIETY
026,435,461,HISTONE,HOWEVER,JUN,KNOCKDOWN,MICROARRAY,NFKB1,PATHWAY,TAKEN,THESE
BURKITT,E2F,FURTHER,PEGYLATED,PEP,TREATMENT
12S,169,BECLIN1,COPYRIGHT,IRELAND,LA1,LTD,MARKERS,PROLONGED,SUCCESSFUL,TAKEN,TOTAL
946,IKK,MAGNESIUM,NK2,SOD,SP1
002,169,19Q13,328,483,CONCLUSION,LABEL,LUCIFERASE,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,SNP
DISRUPTION,HOWEVER,OVERALL
083,MAJOR,THESE
169,DDX3X,EXPRESSION,INCREASED,LABEL,PROTEOMIC,SEC62,SNAI2,THESE,TLOC1,UNLABELLED
BASED,FINALLY,NSCLC,PPI
001,004,006,008,013,025,177,533,869,880,ABC,AFTER,AMONG,CANDIDATE,CHECK,ENRICHMENT,JNK,NRAGE,NSCLC,PARTP,PATHWAY,PGSEA,POINT,PRODUCT,SET,SIGNALING,SIGNALS,SNP,TRUNCATED
FINALLY,FLUOS,MTT,NSCLC,NUCLEAR,PCR
GIVEN,HOWEVER,HSVTK,USING,VSV
146AG,ASIAN,CHINESE,CIS,CRC,HCC,HOWEVER,INDIA,KOREA,MICRORNAS,NORTH,ORS,WHEREAS,WHILE
1082A,439,ADC,ATA,BACKGROUND,CONCLUSION,COX,LABEL,MATERIALS,MEIER,METHODS,PCR,RESLUTS,RFS,SCC
169,946,AMONG,CIP2A,CONCLUSION,COX,EBP,HOWEVER,HPV,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,TL1,TL4
EMT,HOWEVER,SORAFENIB,WIDESPREAD
775,ATLAS,DETECTION,EBV,EPSTEIN,HEPATITIS,HPV,SEQ,VIRAL,WHILE
004,052,501,576,BACKGROUND,CHINESE,CLPTM1L,CONCLUSION,LABEL,METHODS,RESULTS
946,BACH1,INSTEAD,KNOCKDOWN,SMADS,TGF
169,BASED,COPYRIGHT,EHE,FUSIONSEQ,INC,PCR,WILEY,WWTR1
012,016,280,660,736,924,ARG,EUROPEANS,HOWEVER,OVERALL,THEREFORE,XRCC1
945,AFTER,HIF,HOWEVER
160,MARCH
945,APOPTOSIS,BACKGROUND,BAX,BCL,CURRENT,H37,LABEL,METHODS,RESULTS,SALMONELLA,THERE,TNF,TUNEL,WESTERN
DENDRIX,MULTI,THESE
169,COPYRIGHT,FOCAL,HOWEVER,INC,MYC,MYCL1,NOTABLY,RLF,SCLCS,WILEY
001,048,049,ACCORDING,ARG,BASED,CAUCASIANS,CONCERNING,ORS,PRO,SCIENCE,SIMILAR,WANFANG,WEB
020,043,215,BASED,CD133,COX,FUNCTIONAL,SNP
169,256,293,327,ATXN7L2,HOUSTON,ITIH2,LEMD3,NSCLC,NUDT5,ROCHESTER,TAIWANESE,TEXAS,THESE,TMBIM,UNIVERSITY
201,326,399,751,ADC,CHINA,CHINESE,GENOMIC,HAN,HOWEVER,HUNAN,THERE,XPD,XRCC1
293,ACTIVATION,TNM
003,17Q24,215,333,474,ADDITIONAL,AGA,CANDIDATE,COLORECTAL,INITIATIVE,NEIL3,OVARIAN,SCREENING,THEREFORE,THREE,WHI,WOMEN
15E,945,946,ACTIVATION,AKT,BACKGROUND,CONCLUSION,FINALLY,HOWEVER,LABEL,RAC,RAR,RESULTS,THESE
AKT,HOWEVER,IKBKE,S644A,SER32,SERS644,THESE
169,COPYRIGHT,FOXP3,H3K27,NOW,THESE
ERK,GP130,JANUS,LIF,OSM,STATS
001,169,232,EAGLE,FDR,HFE,HPX,INC,MTHFR,SIXTY,THRESHOLD,TNF,TPO,U133A,WILEY,WNT
ERK,FOS,H1299,HBE,JNK,JUN,MMP,THESE,U0126
124,128,214,287,64257,946,947,95C,BACKGROUND,BISUL,BSP,CPG,HBE,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,TGF,WESTERN
005,160,379,382,761,AFTER,ARG,ARG399GLN,CYS,GENOTYPES,GLN,HOWEVER,LYS,LYS751GLN,LYS939GLN,SER,SER326CYS,XPC,XPD,XRCC1
EPIGENETIC,NUCLEOSIDE,RASSF1A,RUNX3,TSG
159,169,BACKGROUND,CONCLUSION,COPYRIGHT,D19S878,D19S886,HOWEVER,IRELAND,LABEL,LIVER,LOH,LTD,METHODS,MUTATIONS,RESULTS,THESE
012,037,169,CHINESE,HOWEVER,INC,RAS,SIPA1,SNP,THREE,WILEY
100,169,ALK,AUTHORS,BRITAIN,DIAGNOSTIC,FGFR3,GREAT,IRELAND,JOURNAL,LTD,ONCOGENIC,PATHOLOGY,SOCIETY,WILEY
CHINESE,HAN,NSCLC,PCA,SIMULATED,SIR,SNP
11424,611,654,795,801,842,891,981,BACKGROUND,BESIDES,CHINESE,CLPTM1L,CONCLUSION,LABEL,RESULTS
008,214,CAUCASIANS,CCND1,G870A,HOWEVER,INCREASING,MAY,MIXED
AFTER,CCL19,CHROMATIN,FOLLOWING,GGGGC,HOWEVER,NSCLC,SP1,THESE
169,COPYRIGHT,ERK,FAK,MACRONB,MICRONB,THESE,UTILIZING
ALK,RET,SINCE
042,215,798,HOWEVER,THESE
BP1,FGF,REDUCTION,THEREFORE
945,946,NUCLEAR,OVCAR,STAT1,THYROID
116,126,169,AFTER,ASSAY,BLOCKED,CBMNCYT,COPYRIGHT,INC,NNK,SEVERAL,WILEY
004,013,014,024,169,1ST,420,993,ASIAN,BACKGROUND,BIOMEDICAL,CAUCASIAN,CHINESE,COPYRIGHT,CROWN,FORTY,FURTHER,HOWEVER,LABEL,METHODS,PUBLISHED,RESULTS,SCIENCE,SEPTEMBER,STATA,WEB
001,002,169,COPYRIGHT,H4K16,INC,MICROARRAY,NSCLC,THESE
135,169,946,CONCLUSION,COPYRIGHT,IHC,INHERITED,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
ADR,CHROMATIN,CONSISTENT,H1299,HDAC6,RUNX2,TAKEN
001,049,115,COX,LOG,LYS751GLN,NSCLC,PFS,WHILE,XPA,XPA23,XPD
001,002,008,014,028,038,039,200,551,597,763,BACKGROUND,FURTHER,LABEL,METHODS,PCR,RASSF1A,RESULTS,THERE,THESE
600,CGH,CNV,FOCUSED,KDM1A,LFS,REMARKABLY,SIRT3,TRRAP,USING
169,ALK,COPYRIGHT,FEW,HOWEVER,LTD,MET,NSCLC,ONCOGENIC,RAS,RET,ROS,THESE
005,169,203,283,AES,APEX1,CENPE,CONCLUSION,COPYRIGHT,GSTP1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,SNP
THESE,USING
002,003,007,008,012,039,040,196A2,BACKGROUND,BESIDES,CIS,EUROPEANS,LABEL,ORS,PRINCIPAL,RESULTS,SEVERAL
169,886,924,946,NCI,SMALL,TGF
EDNRA,GATA2,HOWEVER,KNOWN
860,HOWEVER,PREVIOUSLY
00021,107,633,AFFYMETRIX,AFTERWARDS,AHNAK,AUGMENTING,BACKGROUND,COX,FINALLY,FIRST,GLS,HOWEVER,INSTITUTE,ITGA3,LABEL,METHODS,NCI,RAI14,RESULTS
LITERATURE,MET,THEREFORE
ACUTE,GAS41,THESE
060,1151T,169,93G,ASIAN,BACKGROUND,CBM,COPYRIGHT,FINALLY,FURTHER,HOWEVER,ISI,LABEL,MANAGER,MED,METHODS,OVERALL,PUB,RESULTS,VAL384ASP
946,AMONG,METASTASIS,METASTATIC,TGF,THESE
001,004,016,293,2A6,444,675,694,709,725,794,826,827,909,941,965,ASIAN,CAUCASIAN,CHINESE,CIS,CONCLUSION,CYTOCHROME,KNOWLEDGE,LABEL,LAIRD,LIBRARY,METHODS,OBJECTIVE,OBJECTIVES,ORS,OVERALL,RESULTS,SCIENCE,WEB,WILEY
194,946,MICRORNAS,TGF,THESE
CONSISTENT,CONVERSELY,H1299,P53,SP1
169,POL,STAT3
169,COPYRIGHT,HOWEVER,IKZF1,INC,WILEY
16INK4A,175,652,BACKGROUND,CONCLUSION,CPG,EMBSE,FREQUENCY,GENERALLY,LABEL,MEDLINE,METHODS,NSCLC,RESULTS
15Q25,300,401,468,495,637,855,ADDITIONAL,CAUCASIAN,CHINESE,CIGARETTE,HAN,OVERALL,SNP
ALK,COMPANION,FDA,HOWEVER,KIT
336,500,819TT,942,ASIAN,CIS,HOWEVER,ORS,OVERALL
002,11Q13,19Q13,251,979,ASHKENAZIC,AUC,BACKGROUND,CONCLUSION,LABEL,MEN,METHODS,ORS,POPULATION,RESULTS,THESE
ECH,KEAP1,KELCH,SNP,THESE,WHILE
DIAGNOSTIC,EXOME,GENOMIC
400,DESPITE,THESE
BESIDES,CCND1,EPIDERMAL,HDAC1,HOWEVER,PML,PMLIV
100,BACKGROUND,COLORECTAL,CRC,HCT116B,HOWEVER,LABEL,MATERIALS,METHODS,MICROARRAY,RESULTS
197,239,AMONG,BACKGROUND,BCL,BIM,HOWEVER,LABEL,METHODS,NSCLC,PFS,RESULTS,SEOUL,T790M,TKI,TREATMENT,UNIVERSITY
EMT,FK506,MCSCS
169,ALK,CAUCASIAN,COPYRIGHT,FDG,IRELAND,LTD,PET,RAS,RET,WHILE
300,BESIDES,H1299,HOWEVER,INK4D,INSERTION,PCR,PTB,REPRESSION,UTR,WESTERN
221,324,BACKGROUND,CONCLUSION,EDNRA,GREM1,HOWEVER,INTEGRATED,KPNA2,LABEL,LOX,METHODS,NOTICEABLY,PROTEIN,RESULTS,SCORE,SINCE,TNFAIP6
139,AMONG,CXCLS,DECREASED,FURTHER,HIF1A,IL6,IMPDH,ORIGINALLY,PAI,U87,USING
CLINICIANS,SMN,USA
016,160,216,662,878,FUNCTIONAL,REDUCED
CHROMATIN,HOWEVER,RFECS
153,169,AFP,CONCLUSION,FINALLY,H19,HCC,HEPG2,LABEL,LIVER,NAD,SIRT6,SIRTUIN,UNLABELLED
450,945,CDS,FURTHER,HIF,HYPOXIA,MTT,NDRG1,NGRG1,RESULTS
BLM,FINALLY,IPF,NOTABLY,THESE
CONVERSELY,GTP,HOWEVER,MICRORNAS,MIR,RHO,THESE,UTR
BACKGROUND,CONCLUSION,LABEL,METHODS,METHYLCAP,NON,NOVEL,NSCLC,RESULTS
008,169,319,AFTER,ARG,BACKGROUND,COPYRIGHT,HPV,INC,LABEL,METHODS,PCR,PUBLISHED,RESULTS,SOCIETY
013,BACKGROUND,CHAIN,CHEMO,CONCLUSION,DHPLC,HOWEVER,IIB,LABEL,MATCHED,MET,METHODS,NSCLC,PCR,POLYMERASE,REFRACTORY,RESULTS,T790M
001,113,181,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEP15
169,901,COPYRIGHT,DESPITE,INC,MAY,MEDLINE,REPORTING,REVIEWS,STUDIES,SYSTEMATIC,THREE,WILEY
012,169,663,755,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,SUBSEQUENT
ALK,BECAUSE,EPIDERMAL,RET,SEVERAL,THROUGH,TKI
020,041,104,216,946,III,LOH,MSI,NSCLC,RAR,SCC,TNM,YEARS
AFTER,NISCH,PCR
376,574,606,BACKGROUND,GREATER,LABEL,OTHER,PAPG1,RESULTS,SWR,THESE
169,DAC,DACH1,DACHSHUND,DROSOPHILA,EGF,ENDOGENOUS,EXPRESSION,GIVEN,NSCLC
31S,COUPLED,DICER,MCF,NOTABLY,UTR,VARIATIONS
001,168,201,CENTRAL,CHINA,GENOMIC,HAN,HUNAN,PCR,SOUTH,THESE
293,FOLLOWING,HEK,IGF,PCR,PREVIOUSLY
008,047,132,160,169,181,735,BACKGROUND,COPYRIGHT,DECREASES,INC,LABEL,MATERIALS,METHODS,MMP,RESULTS
100,106,108,147,450,BACKGROUND,CONCLUSION,GXE,INSTITUTE,LABEL,METHODS,NCI,NIH,RESULTS,THERE,THESE,YEARS
DIGITAL,HOWEVER,VARIATION
945,HOWEVER
945,948,HOWEVER,WORKERS
154,15Q,330,342,366,477,AFRICAN,AMERICANS,AUC,BACKGROUND,BLACK,EXOC2,HOUSTON,HTERT,LABEL,METHODS,RESULTS,SNP,STATE,TEXAS,UNIVERSITY,WAYNE
179,ALK,BACKGROUND,ERBB2,HOWEVER,KIT,LABEL,MASSARRAY,MET,METHODS,MUTATIONS,N375S,ONCOGENIC,PANEL,R988C,RESULTS,SCREENING,USING
CKAP5,CONCLUSION,DESPITE,HNSCC,KIF11,KPNB1,LABEL,METHODS,NSCLC,OBJECTIVE,PHENOTYPES,PURPOSE,RAN,RESULTS
113,137,150,154,169,229,242,339,419,740,AMONG,CRC,MMR,OVERALL,RESPONSES,RRS
15Q25,248,307,NORTH,NOVEL
CCK,CDR,CELLS,CPG,H1299,H1650,HOWEVER,KIT,MSP,NSCLC,PCR,THESE,THREE,WHILE
001,012,037,046,100,GIVEN,MPM,NF2,NSCLC,THESE,WHILE
169,399,466,60YEARS,BACKGROUND,CHINA,CHINESE,CIS,CLPTM1L,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,ORS,POTENTIAL,RESULTS,SCC,TAIYUAN,THESE
946,DAE,OVERALL
EPIGENETIC,NET,RASSF1A
CSC,DEOXY,LIMITED,MICRORNAS,MYC,REPRESSION,SUBSEQUENT,SUZ12,UNDER,WNT,WNT5A
169,BECAUSE,COPYRIGHT,GAUSSIA,IGM,JAPAN,PUBLISHED,SBC,SOCIETY
946,BACKGROUND,BRCA1,HOWEVER,ISL,LABEL,LIN11,LOW,MEC,METHODS,PFS,RESULTS,T790M
120,1288G,CHINESE,MALAYSIAN,MEN
186,ACTIVATING,BACKGROUND,CONCLUSION,LABEL,LAMNS,METHODS,RESULTS
FGFR1,RET
ALK,ALREADY,NSCLC,THESE
169,ADCCS,BLACKWELL,KIT,LABEL,LTD,MASSARRAY,METHODS,MYB,OBJECTIVE,ONCOCARTA,PANEL,PUBLISHING,RAS,RESULTS,USING
126,945,EGFL7,SDF,STROMAL,THESE
100,124,215,AIM,FFPET,IVD,KIT,L858R,LABEL,METHODS,MPP,NPA,NSCLC,OBJECTIVE,OVERALL,PPA,RESULTS,SPECIMENS,THERE
232,BHD,DUB
215,BASED,FALSE,HOWEVER,V600E,V617F
169,2527G,843,85894,ATP,CAUCASIAN,COPYRIGHT,IRELAND,LTD,NSCLC,V843I,WHILE
240,535,651,AFTER,FAS,GIVEN,LUCIFERASE,NSCLC,SNP,THESE
094,215,441,650,699,720,818,CARDS,CONSORTIUM,EPHX2,HLA,NCI,STAGE
1ST,215,2ND,782,784,975,AFTER,CHINESE,CLPTM1L,HAN
100,169,COPYRIGHT,INC,NGS,PCR,WILEY
BECAUSE,FOX,FOXA1,FOXA2,HOWEVER,LHX,SCLCS,THESE,THYROID,TRU
017,038,176,442,ACT,CDKN3,III,JBR,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SPORE,USING
169,442,COPYRIGHT,IRELAND,LTD,THESE,UBE2C
003,215,267,383,FUNCTIONAL,HAPLOTYPE,HOWEVER,SCC,SIRT1
169,COPYRIGHT,IPF,LTD,MUTATIONS,PCR,PROTEIN,SURFACTANT
EARLY
021,036,215,67048,CHINESE,CNV,PCR
009,145,169,328,BCL,CONCLUSION,COX,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RASSF1A,RECURRENCE,RESULTS,RFS
200,28B,EMT,HMGA2,INHIBITION,KNOCK,LIN,MCF,OSM,STAT3,THESE
ALK,BESIDES,EGF,EPIDERMAL,THESE,TREATMENT
939,945,AMONG,CHINESE,MICROARRAY,MMP,NSCLC,USING
946,ACCORDING,CPG,DU145,FIRST,H3K9ME3,LNCAP,PC3,PCR,RAR,WESTERN,WHILE
193,211,634GG,945,946,CHINESE,HAN,IL1,IL6,PCR,TGF
169,945,946,C16,C18,COPYRIGHT,FLORIDA,IMR,INC,INCREASED,KEAP1,MUFAS,NAD,NMR,ROS,SUBSEQUENT,THEIR,TREATMENT
155,FNA,NSCLC,SOMATIC,THEREFORE
169,600,608,BAX,BCL,COPYRIGHT,INC,INRF2,NUCLEAR,SIRNA,THESE,TREATMENT
169,229,AMONG,AZA,BACKGROUND,BISULFITE,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,PCR,REDUCED,RESULTS,THESE,TSA
039,127,155,169,230,ALK,BACKGROUND,COPYRIGHT,FURTHER,INHERITED,IRELAND,LABEL,LTD,METHODS,NEVER,NSCLC,RESULTS
COX,FOXM1,LUCIFERASE,MANGANESE,MEIER,MNSOD,RFS,SP1,THREE,WESTERN
169,COPYRIGHT,GSA,HOWEVER,NUMERICAL,OOB
169,500,AFFYMETRIX,C57BL,CD11B,CONCLUSION,COPYRIGHT,EXPRESSION,GR1,IMC,INC,LABEL,LEWIS,MEASURE,METHODS,OBJECTIVE,OUTCOME,PCR,PUBLISHED,RESULTS,SETTING,SIMILARITY,SOCIETY
019,036,043,228,ERCC5,FURTHER,NSCLC
032,048,BE1,MSP,MTT,PCR,TNM,WNT
167,169,AMONG,CES,COPYRIGHT,DELAYED,DEPRESSION,DEPRESSIVE,FCS,GMM,IL1R2,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESILIENT,RESULTS,STUDIES,VARIATION,VARIATIONS,WHILE
100,CALIFORNIA,GENERAL,PROTECTION,SURGEON,TOBACCO
108,169,522,COPYRIGHT,CYP24A1,CYP27A1,CYP27B1,HNC,SERUM,SPC,THESE,THREE,VDR
001,027,160,169,AMONG,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,GLU_GLU,INC,INSTITUTE,LABEL,LYS_GLU,LYS_LYS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,T251A,THESE
017,037,115,169,177,196,2467T,3113A,3860G,CMR,COPYRIGHT,CYP,INC,ORS,SEVERAL,SIMILARLY,WILEY
403,624,FINALLY,GENOMIC,KNOCKDOWN,NMC,NUCLEAR,NUT,PCR,PER,SEQ,THESE
BACKGROUND,CONVERSELY,DIRECTIONS,EPIGENETIC,FURTHER,LABEL,NADPH,REDOX,RESULTS,ROS
169,BACKGROUND,CONCLUSION,COPYRIGHT,CURRENT,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,THESE,UBIQUITIN
001,002,005,031,155,169,1748A,443,443CC,443TT,826,CONCLUSION,COPYRIGHT,HCC,HOWEVER,HT2,HT3,LABEL,LIVER,OPN,SNP,TTR,UNLABELLED
169,398,BECAUSE,FURIN,INC,INHIBITION,NCI,NCSLC,NSCLC,PCSK4,PCSK6,PCSKS,PTGS2,WILEY
000,169,AMONG,COPYRIGHT,CPG,DECREASED,EBV,EPSTEIN,REPRESSION,THESE
15Q25,169,310,348,COPYRIGHT,NICOTINIC
001,150,15Q25,394,CONFIRMING,CPG,DECITABINE,H1299,PA549,THESE
AMONG,CPG,HAND1,MOTIF,NEUROD1,OWING,SMALL,THESE
946,ARMADILLO,CATENIN,CHROMATIN,DIAP1,DROSOPHILA,ENDOCRINE,HDACS,JNK,NEOPLASIA,RET,RHO,SEQ,SIN3A,SRC,TCF,WNT
106,169,946,BRITAIN,COPYRIGHT,DACT2,EIGHT,GREAT,HOWEVER,IRELAND,LEF,LOH,LTD,MSP,PCR,PUBLISHED,SNP,SOCIETY,TCF,WILEY,WNT,XENOPUS
ARG,DESPITE,EGF,HOWEVER,RAS,SRC,THESE,USING
001,038,169,173,233,ARGONAUTE2,CHINESE,FINALLY,INC,NPC,PCR,RESULTS,TAKEN,THESE,USING,WILEY
001,169,200,375,537,947,GAG,GCL,GSH,INC,PCR,SIMILARLY,THESE,WILEY
AKT,IGFBP,IGFIR,INSULIN,NSCLC
169,59E22,759B7,BAC,CEP,CONCLUSION,COPYRIGHT,D3S1560,D3S1766,D3S2406,D3S2454,FURTHER,III,INC,LABEL,LOH,MEC,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,PCR,RCC,RESULTS,ROH,VALIDATION,VHL
